{"filepath": "../L2M3_data/0_csd_related_papers/ACS_XML/cg201177p.xml", "publisher": "acs", "elements": [{"idx": 1, "type": "text", "classification": ["else"], "content": "<p>Ionic co-crystals (ICCs) are constituted of inorganic salts and organic molecules. These crystals combine ionic interactions with classical supramolecular bonding such as hydrogen and dipole-bonding interactions. Such is the case of the hydrogen bonds between N\u2013H and C\ue5fbO dipoles in primary and secondary amides when these cocrystallize with an ionic material such as CaCl<sub>2</sub>. Here, we report our results of the preparation and characterization of a series of ICCs in which the molecular component is an active pharmaceutical ingredient (API) or a precursor of APIs, namely, barbituric acid, diacetamide, malonamide, nicotinamide, and piracetam, while the inorganic salt coformer is CaCl<sub>2</sub>. CaCl<sub>2</sub> has been chosen, inter alia, for its nontoxicity and potential applications in the pharmaceutical field. Preparative methods include conventional crystallizations from solution, as well as slurry and solid state techniques (grinding and kneading). All crystal structures reported herein were determined either from single crystal diffraction data or from powder diffraction data, using simulated annealing procedures. Crystalline products were analyzed by differential scanning calorimetry, thermogravimetric analysis, and variable temperature X-ray powder diffraction. Intrinsic dissolution rate measurements were also performed on nicotinamide and piracetam ICCs.</p>", "clean_text": "Ionic co-crystals (ICCs) are constituted of inorganic salts and organic molecules. These crystals combine ionic interactions with classical supramolecular bonding such as hydrogen and dipole-bonding interactions. Such is the case of the hydrogen bonds between N-H and C\ue5fbO dipoles in primary and secondary amides when these cocrystallize with an ionic material such as CaCl2. Here, we report our results of the preparation and characterization of a series of ICCs in which the molecular component is an active pharmaceutical ingredient (API) or a precursor of APIs, namely, barbituric acid, diacetamide, malonamide, nicotinamide, and piracetam, while the inorganic salt coformer is CaCl2. CaCl2 has been chosen, inter alia, for its nontoxicity and potential applications in the pharmaceutical field. Preparative methods include conventional crystallizations from solution, as well as slurry and solid state techniques (grinding and kneading). All crystal structures reported herein were determined either from single crystal diffraction data or from powder diffraction data, using simulated annealing procedures. Crystalline products were analyzed by differential scanning calorimetry, thermogravimetric analysis, and variable temperature X-ray powder diffraction. Intrinsic dissolution rate measurements were also performed on nicotinamide and piracetam ICCs.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 2, "type": "text", "classification": ["else"], "content": "<p>The \u201csolvating properties\u201d of a number of amides relevant to the pharmaceutical field, either as APIs or API precursors, toward CaCl<sub>2</sub> are discussed for the synthesis of ionic cocrystals. Cocrystallization of organic molecules with inorganic salts represents a tool for the enhancement of thermal stability and the modification of solubility properties.</p>", "clean_text": "The \"solvating properties\" of a number of amides relevant to the pharmaceutical field, either as APIs or API precursors, toward CaCl2 are discussed for the synthesis of ionic cocrystals. Cocrystallization of organic molecules with inorganic salts represents a tool for the enhancement of thermal stability and the modification of solubility properties.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 3, "type": "text", "classification": ["else"], "content": "<title>Introduction</title><p>Crystal engineers aim to make crystals by design, that is, to assemble molecular or ionic components into a crystalline supramolecular network starting from a knowledge, hence a predictive capacity, of the way molecules\ue5f8the \u201cbuilding blocks\u201d\ue5f8will cling to each other to construct a stable crystalline edifice. In the case of molecular crystals, ionic crystals containing molecular ions, and coordination networks, the interactions between building blocks are mainly of noncovalent nature, for example, coordination bonds between ligands and metal centers, Coulombic attractions and repulsions between ions, interactions of the van der Waals type, for example, \u03c0-stacking, interactions between halogen atoms as well as hydrogen bonds in the whole range of strength from weak interactions of the C\u2013H\u00b7\u00b7\u00b7O type to strong \u201ccharge assisted\u201d bonds between ions, and, of course, combinations of these linkages.\n</p>", "clean_text": "Introduction\n\nCrystal engineers aim to make crystals by design, that is, to assemble molecular or ionic components into a crystalline supramolecular network starting from a knowledge, hence a predictive capacity, of the way molecules\ue5f8the \"building blocks\"\ue5f8will cling to each other to construct a stable crystalline edifice. In the case of molecular crystals, ionic crystals containing molecular ions, and coordination networks, the interactions between building blocks are mainly of noncovalent nature, for example, coordination bonds between ligands and metal centers, Coulombic attractions and repulsions between ions, interactions of the van der Waals type, for example, \u03c0-stacking, interactions between halogen atoms as well as hydrogen bonds in the whole range of strength from weak interactions of the C-H\u22c5\u22c5\u22c5O type to strong \"charge assisted\" bonds between ions, and, of course, combinations of these linkages. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 4, "type": "text", "classification": ["else"], "content": "<p>There is a strong current interest in the application of crystal-engineering approaches to the preparation of molecular cocrystals, viz. of stable aggregates of two or more molecular components that form stable crystalline materials on their own at ambient conditions. It is, however, difficult to define a precise difference between co-crystals and other multicomponent aggregates such as solvates, molecular salts (e.g., when proton transfer along a hydrogen bond is involved), and molecular complexes.\n</p>", "clean_text": "There is a strong current interest in the application of crystal-engineering approaches to the preparation of molecular cocrystals, viz. of stable aggregates of two or more molecular components that form stable crystalline materials on their own at ambient conditions. It is, however, difficult to define a precise difference between co-crystals and other multicomponent aggregates such as solvates, molecular salts (e.g., when proton transfer along a hydrogen bond is involved), and molecular complexes. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 5, "type": "text", "classification": ["else"], "content": "<p>Cocrystals are important because of their possible applications in the pharmaceutical field and generally in any field where the final product is used and commercialized as a solid phase. Moreover, cocrystals often show physical and chemical properties (solubility and instrinsic dissolution rate, melting point, color, etc.) that are usually different from those of their separate components. At the same time, the cocrystallization process does not affect the chemical integrity of the molecular compounds\ue5f8this is particularly important in the case of active pharmaceutical ingredients (APIs). At the academic level, the research on molecular cocrystals yields new information on molecular recognition, assembly, and packing.</p>", "clean_text": "Cocrystals are important because of their possible applications in the pharmaceutical field and generally in any field where the final product is used and commercialized as a solid phase. Moreover, cocrystals often show physical and chemical properties (solubility and instrinsic dissolution rate, melting point, color, etc.) that are usually different from those of their separate components. At the same time, the cocrystallization process does not affect the chemical integrity of the molecular compounds\ue5f8this is particularly important in the case of active pharmaceutical ingredients (APIs). At the academic level, the research on molecular cocrystals yields new information on molecular recognition, assembly, and packing.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 6, "type": "text", "classification": ["else"], "content": "<p>Recently, we have reported on a new class of ionic cocrystals (ICCs) formed by an organic molecule and an inorganic salt, like an alkali or alkaline earth halide: In these compounds, the organic molecule, which is solid as a pure compound at ambient conditions, acts as a sort of solvating molecule toward the ions. As a matter of fact, ICCs are often hydrated, and water molecules compete with the organic component for ions coordination. ICCs can be obtained either by classic crystallization methods, i.e., by mixing components in solution in adequate stoichiometric ratios, or by solid-state reactions between solid components (grinding or kneading) with no or limited solvent involvement.</p>", "clean_text": "Recently, we have reported on a new class of ionic cocrystals (ICCs) formed by an organic molecule and an inorganic salt, like an alkali or alkaline earth halide: In these compounds, the organic molecule, which is solid as a pure compound at ambient conditions, acts as a sort of solvating molecule toward the ions. As a matter of fact, ICCs are often hydrated, and water molecules compete with the organic component for ions coordination. ICCs can be obtained either by classic crystallization methods, i.e., by mixing components in solution in adequate stoichiometric ratios, or by solid-state reactions between solid components (grinding or kneading) with no or limited solvent involvement.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 7, "type": "text", "classification": ["else"], "content": "<p>It should be stressed that it is not yet possible to predict whether a certain organic molecule will form an ICC with a given inorganic salt or crystallize out as separate materials. However, a knowledge of preferred hydrogen-bonding interactions of the organic moiety allows some insight. For example, in primary and secondary amides, it is known that N\u2013H and C\ue5fbO groups will act, respectively, as donor and acceptor groups for hydrogen bonds but also as \u201csolvating\u201d groups toward negative and positive ions, respectively. Thus, it is reasonable to consider these molecules as suitable candidates for the design of new ICCs. It has in fact been shown that urea and barbituric acid form ICCs where the C\ue5fbO and N\u2013H dipoles coordinate metal cations and halide anions, respectively. An a priori knowledge of the metal coordination patterns would also be of great advantage.  Unfortunately, the coordination number and geometry of alkaline and alkali earth metals are not easily predictable, and this fact adds problems when the structures need to be determined from powder diffraction data alone, as for some of the cases discussed herein. Crystal structures of the urea<sub>4</sub> \u00b7CaCl <sub>2</sub> and oxamide\u00b7CaCl <sub>2</sub> \u00b72H <sub>2</sub>O ICCs have also been recently solved from powder diffraction data and reported in the context of a paper describing a new crystallographic approach to structure solution from powder diffraction data.\n</p>", "clean_text": "It should be stressed that it is not yet possible to predict whether a certain organic molecule will form an ICC with a given inorganic salt or crystallize out as separate materials. However, a knowledge of preferred hydrogen-bonding interactions of the organic moiety allows some insight. For example, in primary and secondary amides, it is known that N-H and C\ue5fbO groups will act, respectively, as donor and acceptor groups for hydrogen bonds but also as \"solvating\" groups toward negative and positive ions, respectively. Thus, it is reasonable to consider these molecules as suitable candidates for the design of new ICCs. It has in fact been shown that urea and barbituric acid form ICCs where the C\ue5fbO and N-H dipoles coordinate metal cations and halide anions, respectively. An a priori knowledge of the metal coordination patterns would also be of great advantage.  Unfortunately, the coordination number and geometry of alkaline and alkali earth metals are not easily predictable, and this fact adds problems when the structures need to be determined from powder diffraction data alone, as for some of the cases discussed herein. Crystal structures of the urea4 \u22c5CaCl 2 and oxamide\u22c5CaCl 2 \u22c52H 2O ICCs have also been recently solved from powder diffraction data and reported in the context of a paper describing a new crystallographic approach to structure solution from powder diffraction data. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 8, "type": "text", "classification": ["else"], "content": "<p>In the present work, we explore the \u201csolvating properties\u201d toward the inorganic salt CaCl<sub>2</sub> of a number of amides that are relevant to the pharmaceutical field, either as APIs or as precursors for the synthesis of drugs, namely, barbituric acid, urea, oxamide, diacetamide, malonamide, nicotinamide, and piracetam (Figure ). CaCl<sub>2</sub> was chosen as the inorganic counterpart also because of its nontoxicity and potential applications in the pharmaceutical field. The new ICCs discussed hereafter are reported in Table .</p>", "clean_text": "In the present work, we explore the \"solvating properties\" toward the inorganic salt CaCl2 of a number of amides that are relevant to the pharmaceutical field, either as APIs or as precursors for the synthesis of drugs, namely, barbituric acid, urea, oxamide, diacetamide, malonamide, nicotinamide, and piracetam (Figure ). CaCl2 was chosen as the inorganic counterpart also because of its nontoxicity and potential applications in the pharmaceutical field. The new ICCs discussed hereafter are reported in Table .", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 9, "type": "figure", "classification": null, "content": "<fig id=\"fig1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<p>Organic components used in the preparation of ICCs with CaCl<sub>2</sub>.</p>\n</caption>\n<graphic id=\"gr1\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2011-01177p_0001.tif\"></graphic>\n</fig>", "clean_text": " 1  Organic components used in the preparation of ICCs with CaCl2.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 10, "type": "table", "classification": null, "content": "<table-wrap id=\"tbl1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<title>ICCs Obtained as Single Crystals or Powders from Solution and Solid-State Processes</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup align=\"left\" cols=\"3\">\n<oasis:colspec colname=\"col1\"></oasis:colspec>\n<oasis:colspec colname=\"col2\"></oasis:colspec>\n<oasis:colspec colname=\"col3\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\">ICC formula</oasis:entry>\n<oasis:entry align=\"center\">synthesis technique</oasis:entry>\n<oasis:entry align=\"center\">structural solution</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>malonamide\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O</oasis:entry>\n<oasis:entry>solution/kneading</oasis:entry>\n<oasis:entry>single crystal</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>piracetam<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O</oasis:entry>\n<oasis:entry>kneading</oasis:entry>\n<oasis:entry>powder</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O</oasis:entry>\n<oasis:entry>kneading</oasis:entry>\n<oasis:entry>powder</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>nicotinamide<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O</oasis:entry>\n<oasis:entry>solution</oasis:entry>\n<oasis:entry>single crystal</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>diacetamide\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O</oasis:entry>\n<oasis:entry>solution/kneading</oasis:entry>\n<oasis:entry>single crystal</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>barbituric acid\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O</oasis:entry>\n<oasis:entry>solution/kneading</oasis:entry>\n<oasis:entry>single crystal</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>piracetam<sub>2</sub>\u00b7SrCl<sub>2</sub>\u00b72H<sub>2</sub>O</oasis:entry>\n<oasis:entry>solution</oasis:entry>\n<oasis:entry>single crystal</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n</table-wrap>", "clean_text": "", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 11, "type": "text", "classification": ["else"], "content": "<p>Crystal structures were determined either from single crystal data or from powder diffraction data. Crystalline products were analyzed with differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), and variable-temperature X-ray powder diffraction (XRPD). Intrinsic dissolution rate (IDR) measurements were performed on ICCs containing the APIs nicotinamide and piracetam.</p>", "clean_text": "Crystal structures were determined either from single crystal data or from powder diffraction data. Crystalline products were analyzed with differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), and variable-temperature X-ray powder diffraction (XRPD). Intrinsic dissolution rate (IDR) measurements were performed on ICCs containing the APIs nicotinamide and piracetam.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 12, "type": "text", "classification": ["else"], "content": "<title>Experimental Details and Structure Determination from XRPD Data</title><p>All reagents and solvents were purchased from Sigma-Aldrich and used without further purification.</p><title>Synthesis in Solution</title><p>CaCl<sub>2</sub> (0.1 mmol) and 0.1 mmol of the organic precursor were dissolved in 20 mL of absolute ethanol; the solution was left to evaporate at room temperature, yielding crystalline barbituric acid\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O, diacetamide\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O, malonamide\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O, and nicotinamide<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O. Solid piracetam<sub>2</sub>\u00b7SrCl<sub>2</sub>\u00b72H<sub>2</sub>O was obtained by dissolving piracetam (0.2 mmol) and SrCl<sub>2</sub> (0.1 mmol) in 20 mL of absolute ethanol; the solution was left to evaporate at room temperature.</p>", "clean_text": "Experimental Details and Structure Determination from XRPD Data\n\nAll reagents and solvents were purchased from Sigma-Aldrich and used without further purification.\n\nSynthesis in Solution\n\nCaCl2 (0.1 mmol) and 0.1 mmol of the organic precursor were dissolved in 20 mL of absolute ethanol; the solution was left to evaporate at room temperature, yielding crystalline barbituric acid\u22c5CaCl2\u22c55H2O, diacetamide\u22c5CaCl2\u22c55H2O, malonamide\u22c5CaCl2\u22c52H2O, and nicotinamide2\u22c5CaCl2\u22c52H2O. Solid piracetam2\u22c5SrCl2\u22c52H2O was obtained by dissolving piracetam (0.2 mmol) and SrCl2 (0.1 mmol) in 20 mL of absolute ethanol; the solution was left to evaporate at room temperature.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 13, "type": "text", "classification": ["else"], "content": "<title>Solid State Synthesis</title><p>Barbituric acid\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O, diacetamide\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O and malonamide\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O were obtained by manually kneading barbituric acid (1 mmol), urea (4 mmol), oxamide (1 mmol), diacetamide (1 mmol), or malonamide (1 mmol) with CaCl<sub>2</sub> (1 mmol) in an agate mortar for 20 min with a drop of ethanol; all reactions were quantitative. Nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O was obtained by ball milling (using a Retsch MM 200 Mixer Mill) nicotinamide (1 mmol) and CaCl<sub>2</sub> (1 mmol) for 120 min with a drop of ethanol; the reaction was quantitative. Piracetam<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O was obtained by ball milling piracetam (2 mmol) and CaCl<sub>2</sub> (1 mmol) for 120 min with a drop of water; the reaction was quantitative.</p>", "clean_text": "Solid State Synthesis\n\nBarbituric acid\u22c5CaCl2\u22c55H2O, diacetamide\u22c5CaCl2\u22c55H2O and malonamide\u22c5CaCl2\u22c52H2O were obtained by manually kneading barbituric acid (1 mmol), urea (4 mmol), oxamide (1 mmol), diacetamide (1 mmol), or malonamide (1 mmol) with CaCl2 (1 mmol) in an agate mortar for 20 min with a drop of ethanol; all reactions were quantitative. Nicotinamide\u22c5CaCl2\u22c5H2O was obtained by ball milling (using a Retsch MM 200 Mixer Mill) nicotinamide (1 mmol) and CaCl2 (1 mmol) for 120 min with a drop of ethanol; the reaction was quantitative. Piracetam2\u22c5CaCl2\u22c52H2O was obtained by ball milling piracetam (2 mmol) and CaCl2 (1 mmol) for 120 min with a drop of water; the reaction was quantitative.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 14, "type": "text", "classification": ["else"], "content": "<title>TGA</title><p>TGA measurements were performed using a Perkin-Elmer TGA7 in the temperature range 30\u2013400 \u00b0C under an N<sub>2</sub> gas flow, at a heating rate of 5 \u00b0C min<sup>\u20131</sup>.</p><title>DSC</title><p>DSC measurements were performed with a Perkin-Elmer Diamond. Samples (3\u20135 mg) were placed in open aluminum pans. Heating was carried out at 5 \u00b0C min<sup>\u20131</sup> for all cocrystals, in the temperature range 30\u2013160 \u00b0C.</p>", "clean_text": "TGA\n\nTGA measurements were performed using a Perkin-Elmer TGA7 in the temperature range 30-400 \u00b0C under an N2 gas flow, at a heating rate of 5 \u00b0C min-1.\n\nDSC\n\nDSC measurements were performed with a Perkin-Elmer Diamond. Samples (3-5 mg) were placed in open aluminum pans. Heating was carried out at 5 \u00b0C min-1 for all cocrystals, in the temperature range 30-160 \u00b0C.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 15, "type": "text", "classification": "error", "content": "<title>IDR</title><p>Measurements were carried out with a Varian Cary 50 Spectrophotometer equipped with a fiber optic dip probe. Five standard solutions in physiological solution (0.1 M NaCl) at concentrations of 6.25, 12.50, 25.00, 50.00, and 100.00 mg L<sup>\u20131</sup> were used to calculate a calibration curve for both piracetam and nicotinamide (correlation coefficients were 0.99476 and 0.99839, respectively). We analyzed the dissolution rate in water at room temperature of piracetam (commercial, form III), nicotinamide (commercial reagent, form I), piracetam<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O, and nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O. We measured the absorbance and used the linear part of the spectrum between 0.1 and 0.5 min, its slope corresponding to the dissolution rate in that interval of time, expressed in Abs min<sup>\u20131</sup>. The Abs min<sup>\u20131</sup> values were then interpolated in the calibration curve to find the dissolution rate of the analytes expressed as mg L<sup>\u20131</sup> min<sup>\u20131</sup>.</p>", "clean_text": "IDR\n\nMeasurements were carried out with a Varian Cary 50 Spectrophotometer equipped with a fiber optic dip probe. Five standard solutions in physiological solution (0.1 M NaCl) at concentrations of 6.25, 12.50, 25.00, 50.00, and 100.00 mg L-1 were used to calculate a calibration curve for both piracetam and nicotinamide (correlation coefficients were 0.99476 and 0.99839, respectively). We analyzed the dissolution rate in water at room temperature of piracetam (commercial, form III), nicotinamide (commercial reagent, form I), piracetam2\u22c5CaCl2\u22c52H2O, and nicotinamide\u22c5CaCl2\u22c5H2O. We measured the absorbance and used the linear part of the spectrum between 0.1 and 0.5 min, its slope corresponding to the dissolution rate in that interval of time, expressed in Abs min-1. The Abs min-1 values were then interpolated in the calibration curve to find the dissolution rate of the analytes expressed as mg L-1 min-1.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 16, "type": "text", "classification": ["else"], "content": "<title>X-Ray Single-Crystal Diffraction Experiments</title><p>Single-crystal X-ray diffraction data were collected at room temperature with an Oxford Diffraction Xcalibur diffractometer equipped with a CCD detector. Mo K\u03b1 radiation (\u03bb = 0.71073 \u00c5) was used. SHELX97 was used for structure solution and refinement. Nonhydrogen atoms were refined anisotropically. Hydrogen atoms bound to carbon atoms were added in calculated positions. Hydrogen atoms bound to nitrogen and oxygen atoms were located from a Fourier map, and their positions were refined. PLATON and SCHAKAL99 were used for hydrogen-bonding analysis and molecular graphics, respectively. Relevant crystallographic details are listed in Table .</p>", "clean_text": "X-Ray Single-Crystal Diffraction Experiments\n\nSingle-crystal X-ray diffraction data were collected at room temperature with an Oxford Diffraction Xcalibur diffractometer equipped with a CCD detector. Mo K\u03b1 radiation (\u03bb = 0.71073 \u00c5) was used. SHELX97 was used for structure solution and refinement. Nonhydrogen atoms were refined anisotropically. Hydrogen atoms bound to carbon atoms were added in calculated positions. Hydrogen atoms bound to nitrogen and oxygen atoms were located from a Fourier map, and their positions were refined. PLATON and SCHAKAL99 were used for hydrogen-bonding analysis and molecular graphics, respectively. Relevant crystallographic details are listed in Table .", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 17, "type": "table", "classification": null, "content": "<table-wrap id=\"tbl2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<title>Crystallographic Details for Malonamide\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O, Diacetamide\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O, Barbituric Acid\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O, Nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O, Nicotinamide<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O, Piracetam<sub>2</sub>\u00b7SrCl<sub>2</sub>\u00b72H<sub>2</sub>O, and Piracetam<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup align=\"left\" cols=\"8\">\n<oasis:colspec colname=\"col1\"></oasis:colspec>\n<oasis:colspec colname=\"col2\"></oasis:colspec>\n<oasis:colspec colname=\"col3\"></oasis:colspec>\n<oasis:colspec colname=\"col4\"></oasis:colspec>\n<oasis:colspec colname=\"col5\"></oasis:colspec>\n<oasis:colspec colname=\"col6\"></oasis:colspec>\n<oasis:colspec colname=\"col7\"></oasis:colspec>\n<oasis:colspec colname=\"col8\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\"></oasis:entry>\n<oasis:entry align=\"center\">malonamide\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O</oasis:entry>\n<oasis:entry align=\"center\">diacetamide\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O</oasis:entry>\n<oasis:entry align=\"center\">barbituric acid\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O</oasis:entry>\n<oasis:entry align=\"center\">nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O<xref rid=\"t2fn1\"></xref>\n</oasis:entry>\n<oasis:entry align=\"center\">nicotinamide<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O</oasis:entry>\n<oasis:entry align=\"center\">piracetam<sub>2</sub>\u00b7SrCl<sub>2</sub>\u00b72H<sub>2</sub>O</oasis:entry>\n<oasis:entry align=\"center\">piracetam<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O<xref rid=\"t2fn1\"></xref>\n</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>chemical formula</oasis:entry>\n<oasis:entry>C<sub>3</sub>H<sub>10</sub>CaCl<sub>2</sub>N<sub>2</sub>O<sub>4</sub>\n</oasis:entry>\n<oasis:entry>C<sub>4</sub>H<sub>17</sub>CaCl<sub>2</sub>NO<sub>7</sub>\n</oasis:entry>\n<oasis:entry>C<sub>4</sub>H<sub>14</sub>CaCl<sub>2</sub>N<sub>2</sub>O<sub>8</sub>\n</oasis:entry>\n<oasis:entry>C<sub>6</sub>CaCl<sub>2</sub>N<sub>2</sub>O<sub>2</sub>\n</oasis:entry>\n<oasis:entry>C<sub>12</sub>H<sub>16</sub>CaCl<sub>2</sub>N<sub>4</sub>O<sub>4</sub>\n</oasis:entry>\n<oasis:entry>C<sub>12</sub>H<sub>24</sub>SrCl<sub>2</sub>N<sub>4</sub>O<sub>6</sub>\n</oasis:entry>\n<oasis:entry>C<sub>12</sub>CaCl<sub>2</sub>N<sub>4</sub>O<sub>6</sub>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">M</italic>\n<sub>r</sub>\n</oasis:entry>\n<oasis:entry>294.11</oasis:entry>\n<oasis:entry>302.17</oasis:entry>\n<oasis:entry>329.15</oasis:entry>\n<oasis:entry>243.06</oasis:entry>\n<oasis:entry>391.27</oasis:entry>\n<oasis:entry>478.87</oasis:entry>\n<oasis:entry>407.14</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>crystal system</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">P</italic>1\u0305</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">P</italic> 2<sub>1</sub>\n</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">P</italic> 2<sub>1</sub>/<italic toggle=\"yes\">c</italic>\n</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">P</italic>1\u0305</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">C</italic>2/<italic toggle=\"yes\">c</italic>\n</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">P</italic> 2<sub>1</sub>/<italic toggle=\"yes\">n</italic>\n</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">P</italic> 2<sub>1</sub>/<italic toggle=\"yes\">n</italic>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>space group</oasis:entry>\n<oasis:entry>triclinic</oasis:entry>\n<oasis:entry>monoclinic</oasis:entry>\n<oasis:entry>monoclinic</oasis:entry>\n<oasis:entry>triclinic</oasis:entry>\n<oasis:entry>monoclinic</oasis:entry>\n<oasis:entry>monoclinic</oasis:entry>\n<oasis:entry>monoclinic</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">a</italic> (\u00c5)</oasis:entry>\n<oasis:entry>5.9055(4)</oasis:entry>\n<oasis:entry>7.8917(5)</oasis:entry>\n<oasis:entry>8.9583(7)</oasis:entry>\n<oasis:entry>9.6884(2)</oasis:entry>\n<oasis:entry>21.740(1)</oasis:entry>\n<oasis:entry>8.9444(5)</oasis:entry>\n<oasis:entry>8.89548(8)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">b</italic> (\u00c5)</oasis:entry>\n<oasis:entry>8.0258(5)</oasis:entry>\n<oasis:entry>7.2632(5)</oasis:entry>\n<oasis:entry>21.060(2)</oasis:entry>\n<oasis:entry>9.2781(1)</oasis:entry>\n<oasis:entry>6.872(3)</oasis:entry>\n<oasis:entry>9.8519(4)</oasis:entry>\n<oasis:entry>9.6092(1)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">c</italic> (\u00c5)</oasis:entry>\n<oasis:entry>11.5035(6)</oasis:entry>\n<oasis:entry>12.9379(8)</oasis:entry>\n<oasis:entry>8.9583(7)</oasis:entry>\n<oasis:entry>6.1967(1)</oasis:entry>\n<oasis:entry>12.8167(7)</oasis:entry>\n<oasis:entry>11.8823(7)</oasis:entry>\n<oasis:entry>11.9274(1)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b1 (deg)</oasis:entry>\n<oasis:entry>71.208(5)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>103.036(2)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>90</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b2 (deg)</oasis:entry>\n<oasis:entry>80.134(5)</oasis:entry>\n<oasis:entry>102.815(7)</oasis:entry>\n<oasis:entry>130.34(1)</oasis:entry>\n<oasis:entry>98.564(1)</oasis:entry>\n<oasis:entry>117.775(7)</oasis:entry>\n<oasis:entry>106.520(7)</oasis:entry>\n<oasis:entry>108.0589(6)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b3 (deg)</oasis:entry>\n<oasis:entry>85.297(5)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>107.858(2)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>90</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">V</italic> (\u00c5<sup>3</sup>)</oasis:entry>\n<oasis:entry>508.32(5)</oasis:entry>\n<oasis:entry>723.12(8)</oasis:entry>\n<oasis:entry>1288.3(2)</oasis:entry>\n<oasis:entry>502.027(8)</oasis:entry>\n<oasis:entry>1694.1(2)</oasis:entry>\n<oasis:entry>1003.84(9)</oasis:entry>\n<oasis:entry>969.31(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">Z</italic>\n</oasis:entry>\n<oasis:entry>2</oasis:entry>\n<oasis:entry>2</oasis:entry>\n<oasis:entry>4</oasis:entry>\n<oasis:entry>2</oasis:entry>\n<oasis:entry>4</oasis:entry>\n<oasis:entry>2</oasis:entry>\n<oasis:entry>2</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">d</italic>\n<sub>calcd</sub> (mg cm<sup>\u20133</sup>)</oasis:entry>\n<oasis:entry>1.628</oasis:entry>\n<oasis:entry>1.388</oasis:entry>\n<oasis:entry>1.697</oasis:entry>\n<oasis:entry>7.21</oasis:entry>\n<oasis:entry>1.534</oasis:entry>\n<oasis:entry>1.584</oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03bc (mm<sup>\u20131</sup>)</oasis:entry>\n<oasis:entry>1.124</oasis:entry>\n<oasis:entry>0.816</oasis:entry>\n<oasis:entry>0.931</oasis:entry>\n<oasis:entry>7.02</oasis:entry>\n<oasis:entry>0.709</oasis:entry>\n<oasis:entry>2.985</oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b8 range (\u00b0)</oasis:entry>\n<oasis:entry>3.50\u201327.50</oasis:entry>\n<oasis:entry>3.23\u201329.3</oasis:entry>\n<oasis:entry>2.88\u201327.33</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>3.15\u201329.21</oasis:entry>\n<oasis:entry>3.14\u201328.79</oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>reflns collected/unique</oasis:entry>\n<oasis:entry>2625/1715</oasis:entry>\n<oasis:entry>3488/1881</oasis:entry>\n<oasis:entry>5365/2364</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>3759/1561</oasis:entry>\n<oasis:entry>3524/1506</oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">R</italic>\n<sub>int</sub>\n</oasis:entry>\n<oasis:entry>0.011</oasis:entry>\n<oasis:entry>0.019</oasis:entry>\n<oasis:entry>0.022</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>0.026</oasis:entry>\n<oasis:entry>0.028</oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>GoF</oasis:entry>\n<oasis:entry>0.845</oasis:entry>\n<oasis:entry>1.059</oasis:entry>\n<oasis:entry>1.05</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>1.093</oasis:entry>\n<oasis:entry>0.933</oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">R</italic>\n<sub>1</sub> (obsd)</oasis:entry>\n<oasis:entry>0.0251</oasis:entry>\n<oasis:entry>0.0551</oasis:entry>\n<oasis:entry>0.0318</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>0.0384</oasis:entry>\n<oasis:entry>0.0377</oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">wR</italic>\n<sub>2</sub> (all)</oasis:entry>\n<oasis:entry>0.0682</oasis:entry>\n<oasis:entry>0.1497</oasis:entry>\n<oasis:entry>0.0715</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>0.088</oasis:entry>\n<oasis:entry>0.0750</oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">R</italic>\n<sub>wp</sub>\n</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>7.21</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>9.11</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">R</italic>\n<sub>\n<italic toggle=\"yes\">F</italic>2</sub>\n</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>7.02</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>9.54</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03c7<sup>2</sup>\n</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>1.031</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>2.202</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t2fn1\">\n<label>a</label>\n<p>Powder data.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 18, "type": "text", "classification": ["else"], "content": "<title>XRPD Experiments</title><p>For structure solution and refinement purposes, X-ray powder diffractograms in the 2\u03b8 range 5\u201370\u00b0 (step size, 0.01\u00b0; time/step, 50 s; 0.02 rad soller; VxA 40 \u00d7 40) were collected on a Panalytical X'Pert PRO automated diffractometer equipped with an X'Celerator detector. For phase identification purposes, X-ray powder diffractograms in the 2\u03b8 range 5\u201340\u00b0 (step size, 0.02\u00b0; time/step, 20 s; 0.04 rad soller; VxA 40 \u00d7 40) were collected on a Panalytical X\u2019Pert PRO automated diffractometer equipped with an X'Celerator detector. All data were collected in Bragg\u2013Brentano geometry, using Cu K\u03b1 radiation without a monochromator.</p>", "clean_text": "XRPD Experiments\n\nFor structure solution and refinement purposes, X-ray powder diffractograms in the 2\u03b8 range 5-70\u00b0 (step size, 0.01\u00b0; time/step, 50 s; 0.02 rad soller; VxA 40 \u00d7 40) were collected on a Panalytical X'Pert PRO automated diffractometer equipped with an X'Celerator detector. For phase identification purposes, X-ray powder diffractograms in the 2\u03b8 range 5-40\u00b0 (step size, 0.02\u00b0; time/step, 20 s; 0.04 rad soller; VxA 40 \u00d7 40) were collected on a Panalytical X'Pert PRO automated diffractometer equipped with an X'Celerator detector. All data were collected in Bragg-Brentano geometry, using Cu K\u03b1 radiation without a monochromator.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 19, "type": "text", "classification": ["else"], "content": "<title>Variable Temperature X-Ray Diffraction</title><p>X-ray powder diffractograms in the 2\u03b8 range 5\u201350\u00b0 were collected on a Panalytical X'Pert PRO automated diffractometer equipped with an X'Celerator detector and an Anton Paar TTK 450 system for measurements at controlled temperature. The data were collected in open air in Bragg\u2013Brentano geometry using Cu K\u03b1 radiation without a monochromator.</p>", "clean_text": "Variable Temperature X-Ray Diffraction\n\nX-ray powder diffractograms in the 2\u03b8 range 5-50\u00b0 were collected on a Panalytical X'Pert PRO automated diffractometer equipped with an X'Celerator detector and an Anton Paar TTK 450 system for measurements at controlled temperature. The data were collected in open air in Bragg-Brentano geometry using Cu K\u03b1 radiation without a monochromator.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 20, "type": "text", "classification": "error", "content": "<title>Structure Determination of Piracetam<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O</title><p>The crystal structure of piracetam<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O could not be solved directly from powder diffraction data by simulated annealing, due to strong preferential orientation effects. The problem was circumvented by preparing and growing single crystals of piracetam<sub>2</sub>\u00b7SrCl<sub>2</sub>\u00b72H<sub>2</sub>O, which turned out to be isostructural with piracetam<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O. The single-crystal structure determination of the strontium ICC allowed both solution by analogy and refinement by Rietveld analysis of the calcium compound. Rietveld refinement was performed with the software GSAS. A shifted Chebyshev with 8 coefficients and a Pseudo-Voigt function (type 4) were used to fit background and peak shape, respectively. A spherical harmonics model was used to describe preferred orientation. Soft constraints were applied on bond distances and angles of both molecules. One overall thermal parameter was adopted for piracetam heterocycle and another one for piracetam amide group. Refinement converged with \u03c7<sup>2</sup> = 2.202, <italic toggle=\"yes\">R</italic>\n<sub>wp</sub> = 9.11, and <italic toggle=\"yes\">R</italic>\n<sub>\n<italic toggle=\"yes\">F</italic>2</sub> = 9.54. Figure  shows experimental, calculated, and difference curves.</p>", "clean_text": "Structure Determination of Piracetam2\u22c5CaCl2\u22c52H2O\n\nThe crystal structure of piracetam2\u22c5CaCl2\u22c52H2O could not be solved directly from powder diffraction data by simulated annealing, due to strong preferential orientation effects. The problem was circumvented by preparing and growing single crystals of piracetam2\u22c5SrCl2\u22c52H2O, which turned out to be isostructural with piracetam2\u22c5CaCl2\u22c52H2O. The single-crystal structure determination of the strontium ICC allowed both solution by analogy and refinement by Rietveld analysis of the calcium compound. Rietveld refinement was performed with the software GSAS. A shifted Chebyshev with 8 coefficients and a Pseudo-Voigt function (type 4) were used to fit background and peak shape, respectively. A spherical harmonics model was used to describe preferred orientation. Soft constraints were applied on bond distances and angles of both molecules. One overall thermal parameter was adopted for piracetam heterocycle and another one for piracetam amide group. Refinement converged with \u03c72 = 2.202, R wp = 9.11, and R  F2 = 9.54. Figure  shows experimental, calculated, and difference curves.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 21, "type": "figure", "classification": null, "content": "<fig id=\"fig2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<p>Experimental (red crosses), calculated (green curve), and difference (purple curve) powder patterns for piracetam<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O; the <italic toggle=\"yes\">x</italic>-axis is in degrees of 2\u03b8. Peak positions are marked in black.</p>\n</caption>\n<graphic id=\"gr2\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2011-01177p_0002.tif\"></graphic>\n</fig>", "clean_text": " 2  Experimental (red crosses), calculated (green curve), and difference (purple curve) powder patterns for piracetam2\u22c5CaCl2\u22c52H2O; the x-axis is in degrees of 2\u03b8. Peak positions are marked in black.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 22, "type": "text", "classification": "error", "content": "<title>Structure Determination of Nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O</title><p>Powder diffraction data were analyzed with the software EXPO2010, the updated version of EXPO2009, which is designed to analyze either monochromatic and nonmonochromatic data. Peaks were automatically chosen in the 2\u03b8 range 5\u201340\u00b0, and a triclinic cell was found, using the algorithm N-TREOR, with a volume of 502 \u00c5<sup>3</sup>. The volume is consistent with the presence of two nicotinamide\u00b7CaCl<sub>2</sub> units plus two or four water molecules; therefore, the structure was likely to be centrosymmetric (space group nr. 2, <italic toggle=\"yes\">P</italic>1\u0305), with <italic toggle=\"yes\">Z</italic> = 2 and <italic toggle=\"yes\">Z</italic>\u2032 = 1. The structure was then solved by simulated annealing using (i) one nicotinamide molecule, (ii) one Ca<sup>2+</sup>\u00b7\u00b7\u00b7O<sub>water</sub> or Ca<sup>2+</sup>\u00b7\u00b7\u00b7(O<sub>water</sub>)<sub>2</sub> fragment taken from known structures of similar compounds, (iii) two independent chloride ions, and (iv) one or two independent water molecules. Ten runs per simulated annealing trial were set, and various cooling rates (defined as the ratio <italic toggle=\"yes\">T<sub>n</sub>\n</italic>/<italic toggle=\"yes\">T</italic>\n<sub>\n<italic toggle=\"yes\">n</italic>\u20131</sub>), from 0.90 to 0.98, were used. Several trials with different fragments were performed assuming the formula to be either nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O or nicotinamide\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O: Most solutions with two water molecules per formula unit showed an overlapping of the water molecules, thus indicating the presence of only one water molecule per formula unit. The best solution consistent with the formula nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O was chosen for a Rietveld refinement, which was performed with the software GSAS. A shifted Chebyshev function with eight parameters and a Pseudo-Voigt function (type 4) were used to fit background and peak shape, respectively. Soft costraints were applied on bond distances and angles of the nicotinamide molecule, and a planar group restraint was applied to the aromatic ring. An overall thermal parameter for atoms of the same element in the nicotinamide molecule was adopted. Refinement converged with \u03c7<sup>2</sup> = 1.031, <italic toggle=\"yes\">R</italic>\n<sub>wp</sub> = 7.21, and <italic toggle=\"yes\">R</italic>\n<sub>\n<italic toggle=\"yes\">F</italic>2</sub>= 7.02. Figure  shows the experimental, calculated, and difference diffraction patterns.</p>", "clean_text": "Structure Determination of Nicotinamide\u22c5CaCl2\u22c5H2O\n\nPowder diffraction data were analyzed with the software EXPO2010, the updated version of EXPO2009, which is designed to analyze either monochromatic and nonmonochromatic data. Peaks were automatically chosen in the 2\u03b8 range 5-40\u00b0, and a triclinic cell was found, using the algorithm N-TREOR, with a volume of 502 \u00c53. The volume is consistent with the presence of two nicotinamide\u22c5CaCl2 units plus two or four water molecules; therefore, the structure was likely to be centrosymmetric (space group nr. 2, P1\u0305), with Z = 2 and Z' = 1. The structure was then solved by simulated annealing using (i) one nicotinamide molecule, (ii) one Ca2+\u22c5\u22c5\u22c5Owater or Ca2+\u22c5\u22c5\u22c5(Owater)2 fragment taken from known structures of similar compounds, (iii) two independent chloride ions, and (iv) one or two independent water molecules. Ten runs per simulated annealing trial were set, and various cooling rates (defined as the ratio Tn /T  n-1), from 0.90 to 0.98, were used. Several trials with different fragments were performed assuming the formula to be either nicotinamide\u22c5CaCl2\u22c5H2O or nicotinamide\u22c5CaCl2\u22c52H2O: Most solutions with two water molecules per formula unit showed an overlapping of the water molecules, thus indicating the presence of only one water molecule per formula unit. The best solution consistent with the formula nicotinamide\u22c5CaCl2\u22c5H2O was chosen for a Rietveld refinement, which was performed with the software GSAS. A shifted Chebyshev function with eight parameters and a Pseudo-Voigt function (type 4) were used to fit background and peak shape, respectively. Soft costraints were applied on bond distances and angles of the nicotinamide molecule, and a planar group restraint was applied to the aromatic ring. An overall thermal parameter for atoms of the same element in the nicotinamide molecule was adopted. Refinement converged with \u03c72 = 1.031, R wp = 7.21, and R  F2= 7.02. Figure  shows the experimental, calculated, and difference diffraction patterns.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 23, "type": "figure", "classification": null, "content": "<fig id=\"fig3\" orientation=\"portrait\" position=\"float\">\n<label>3</label>\n<caption>\n<p>Experimental (red crosses), calculated (green curve), and difference (purple curve) powder patterns for nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O; the <italic toggle=\"yes\">x</italic>-axis is in degrees of 2\u03b8. Peak positions are marked in black.</p>\n</caption>\n<graphic id=\"gr3\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2011-01177p_0003.tif\"></graphic>\n</fig>", "clean_text": " 3  Experimental (red crosses), calculated (green curve), and difference (purple curve) powder patterns for nicotinamide\u22c5CaCl2\u22c5H2O; the x-axis is in degrees of 2\u03b8. Peak positions are marked in black.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 24, "type": "text", "classification": ["else"], "content": "<title>Results and Discussion</title><p>Figure  shows a schematic representation of the ICCs structures with CaCl<sub>2</sub> discussed herein (see also Table ). It is easy to appreciate how in all of these ICCs, the organic molecules act as kind of special \u201csolvent molecules\u201d toward calcium chloride. The C\ue5fbO dipoles establish electrostatic interactions with the calcium cations, while the N\u2013H dipoles form hydrogen bonds with the chloride anions. When the cocrystal is a hydrate, the organic molecules are in competition with water in the coordination effort.</p>", "clean_text": "Results and Discussion\n\nFigure  shows a schematic representation of the ICCs structures with CaCl2 discussed herein (see also Table ). It is easy to appreciate how in all of these ICCs, the organic molecules act as kind of special \"solvent molecules\" toward calcium chloride. The C\ue5fbO dipoles establish electrostatic interactions with the calcium cations, while the N-H dipoles form hydrogen bonds with the chloride anions. When the cocrystal is a hydrate, the organic molecules are in competition with water in the coordination effort.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 25, "type": "figure", "classification": null, "content": "<fig id=\"fig4\" orientation=\"portrait\" position=\"float\">\n<label>4</label>\n<caption>\n<p>Packing patterns for (a) malonamide\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O, (b) piracetam<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O, (c) nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O, (d) nicotinamide<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O, (e) diacetamide\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O, and (f) barbituric acid\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O. Color codes: orange, calcium cations and coordination polyhedra; green, chloride ions; gray, carbon; blue, nitrogen; and red, oxygen. Hydrogen atoms not shown for clarity. The software TOPOS was used for all graphical representations.<xref ref-type=\"bibr\" rid=\"ref13\"></xref>\n</p>\n</caption>\n<graphic id=\"gr4\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2011-01177p_0004.tif\"></graphic>\n</fig>", "clean_text": " 4  Packing patterns for (a) malonamide\u22c5CaCl2\u22c52H2O, (b) piracetam2\u22c5CaCl2\u22c52H2O, (c) nicotinamide\u22c5CaCl2\u22c5H2O, (d) nicotinamide2\u22c5CaCl2\u22c52H2O, (e) diacetamide\u22c5CaCl2\u22c55H2O, and (f) barbituric acid\u22c5CaCl2\u22c55H2O. Color codes: orange, calcium cations and coordination polyhedra; green, chloride ions; gray, carbon; blue, nitrogen; and red, oxygen. Hydrogen atoms not shown for clarity. The software TOPOS was used for all graphical representations.    ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 26, "type": "text", "classification": ["else"], "content": "<p>The calcium coordination polyhedra in the various crystals expectedly show large differences in shape and in the number of coordinating atoms. In malonamide\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O, for example, two malonamide molecules, two water molecules, and two chloride anions are coordinated to the calcium cation, which lies on a crystallographic inversion center (Figure a). In the two isomorphous compounds piracetam<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O and piracetam<sub>2</sub>\u00b7SrCl<sub>2</sub>\u00b72H<sub>2</sub>O, on the other hand, four piracetam molecules and two water molecules are involved in the coordination of the calcium cation (Figure b). In both the monohydrate nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O and the dihydrate nicotinamide<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O, the calcium cation interacts with two nicotinamide molecules, the difference between the two systems being in the relative number of water molecules and chloride ions in the coordination polyhedra, which is two and two, and one water molecule and three in the two cocrystals, respectively (Figure c,d). Furthermore, the polyhedra share a Cl\u2013Cl edge two by two in nicotinamide<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O. The coordination polyhedron is a pentagonal bipyramid (coordination seven) in diacetamide\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O (Figure e): The calcium cations interact with both C\ue5fbO terminations of one diacetamide molecule and five water molecules each. The coordination polyhedron is instead a bicapped trigonal prism (coordination eight) in barbituric acid\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O (Figure f) with the calcium cations interacting with three barbituric acid molecules and five water molecules and the polyhedra sharing one water\u2013water edge two by two.</p>", "clean_text": "The calcium coordination polyhedra in the various crystals expectedly show large differences in shape and in the number of coordinating atoms. In malonamide\u22c5CaCl2\u22c52H2O, for example, two malonamide molecules, two water molecules, and two chloride anions are coordinated to the calcium cation, which lies on a crystallographic inversion center (Figure a). In the two isomorphous compounds piracetam2\u22c5CaCl2\u22c52H2O and piracetam2\u22c5SrCl2\u22c52H2O, on the other hand, four piracetam molecules and two water molecules are involved in the coordination of the calcium cation (Figure b). In both the monohydrate nicotinamide\u22c5CaCl2\u22c5H2O and the dihydrate nicotinamide2\u22c5CaCl2\u22c52H2O, the calcium cation interacts with two nicotinamide molecules, the difference between the two systems being in the relative number of water molecules and chloride ions in the coordination polyhedra, which is two and two, and one water molecule and three in the two cocrystals, respectively (Figure c,d). Furthermore, the polyhedra share a Cl-Cl edge two by two in nicotinamide2\u22c5CaCl2\u22c52H2O. The coordination polyhedron is a pentagonal bipyramid (coordination seven) in diacetamide\u22c5CaCl2\u22c55H2O (Figure e): The calcium cations interact with both C\ue5fbO terminations of one diacetamide molecule and five water molecules each. The coordination polyhedron is instead a bicapped trigonal prism (coordination eight) in barbituric acid\u22c5CaCl2\u22c55H2O (Figure f) with the calcium cations interacting with three barbituric acid molecules and five water molecules and the polyhedra sharing one water-water edge two by two.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 27, "type": "figure", "classification": null, "content": "<fig id=\"fig5\" orientation=\"portrait\" position=\"float\">\n<label>5</label>\n<caption>\n<p>Coordination polyhedra around the calcium cation in (a) malonamide\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O, (b) piracetam<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O, (c) nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O, (d) nicotinamide<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O, (e) diacetamide\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O, and (f) barbituric acid\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O. Color codes: orange, calcium cations; green, chloride ions; blue, nitrogen; red, amido oxygen; and light blue, water oxygen.</p>\n</caption>\n<graphic id=\"gr5\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2011-01177p_0005.tif\"></graphic>\n</fig>", "clean_text": " 5  Coordination polyhedra around the calcium cation in (a) malonamide\u22c5CaCl2\u22c52H2O, (b) piracetam2\u22c5CaCl2\u22c52H2O, (c) nicotinamide\u22c5CaCl2\u22c5H2O, (d) nicotinamide2\u22c5CaCl2\u22c52H2O, (e) diacetamide\u22c5CaCl2\u22c55H2O, and (f) barbituric acid\u22c5CaCl2\u22c55H2O. Color codes: orange, calcium cations; green, chloride ions; blue, nitrogen; red, amido oxygen; and light blue, water oxygen.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 28, "type": "text", "classification": ["else"], "content": "<p>Structural properties and organization make ICCs analogous to solvates and hydrates of inorganic salts. Therefore, the presence of hydrogen-bonding acceptor sites on the organic components brings about additional supramolecular requirements that have to be fulfilled on construting the new crystalline edifices, which also accounts for the stability of the cocrystal with respect to the organic and inorganic components separately. Relevant hydrogen-bonding interactions involving the organic moieties are visualized in Figure .</p>", "clean_text": "Structural properties and organization make ICCs analogous to solvates and hydrates of inorganic salts. Therefore, the presence of hydrogen-bonding acceptor sites on the organic components brings about additional supramolecular requirements that have to be fulfilled on construting the new crystalline edifices, which also accounts for the stability of the cocrystal with respect to the organic and inorganic components separately. Relevant hydrogen-bonding interactions involving the organic moieties are visualized in Figure .", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 29, "type": "figure", "classification": null, "content": "<fig id=\"fig6\" orientation=\"portrait\" position=\"float\">\n<label>6</label>\n<caption>\n<p>Relevant hydrogen-bonding interactions involving the organic moieties in (a) barbituric acid\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O [O<sub>CO</sub>\u00b7\u00b7\u00b7(H)O<sub>water</sub> in the range 2.809(3)\u20132.982(3); N(H)\u00b7\u00b7\u00b7Cl<sup>\u2013</sup>, 3.263(4) and 3.275(3) \u00c5], (b) diacetamide\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O [O<sub>CO</sub>\u00b7\u00b7\u00b7(H)O<sub>water</sub>, 2.777(8) and 2.993(7); N(H)\u00b7\u00b7\u00b7Cl<sup>\u2013</sup>, 3.227(5) \u00c5], (c) malonamide\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O [N(H)\u00b7\u00b7\u00b7Cl<sup>\u2013</sup> in the range 3.310(2)\u20133.481(2); N(H)\u00b7\u00b7\u00b7O<sub>water</sub>, 3.144(3) \u00c5], (d) nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O [N(H)\u00b7\u00b7\u00b7Cl<sup>\u2013</sup>, 3.29(1) and 3.31(1)], (e) nicotinamide<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O [N(H)\u00b7\u00b7\u00b7Cl<sup>\u2013</sup>, 3.380(3); N(H)\u00b7\u00b7\u00b7N, 2.953(2) \u00c5], and (f) piracetam<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O [N(H)\u00b7\u00b7\u00b7Cl<sup>\u2013</sup>, 3.42(1) and 3.63(1) \u00c5; H atoms not located, but N(H)\u00b7\u00b7\u00b7Cl hydrogen bonds are comparable to those observed in the Sr analogue]. Color codes are as in Figure <xref rid=\"fig5\"></xref>; gray, carbon; light gray, hydrogen. H<sub>water</sub> atoms are not shown for clarity.</p>\n</caption>\n<graphic id=\"gr6\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2011-01177p_0006.tif\"></graphic>\n</fig>", "clean_text": " 6  Relevant hydrogen-bonding interactions involving the organic moieties in (a) barbituric acid\u22c5CaCl2\u22c55H2O [OCO\u22c5\u22c5\u22c5(H)Owater in the range 2.809(3)-2.982(3); N(H)\u22c5\u22c5\u22c5Cl-, 3.263(4) and 3.275(3) \u00c5], (b) diacetamide\u22c5CaCl2\u22c55H2O [OCO\u22c5\u22c5\u22c5(H)Owater, 2.777(8) and 2.993(7); N(H)\u22c5\u22c5\u22c5Cl-, 3.227(5) \u00c5], (c) malonamide\u22c5CaCl2\u22c52H2O [N(H)\u22c5\u22c5\u22c5Cl- in the range 3.310(2)-3.481(2); N(H)\u22c5\u22c5\u22c5Owater, 3.144(3) \u00c5], (d) nicotinamide\u22c5CaCl2\u22c5H2O [N(H)\u22c5\u22c5\u22c5Cl-, 3.29(1) and 3.31(1)], (e) nicotinamide2\u22c5CaCl2\u22c52H2O [N(H)\u22c5\u22c5\u22c5Cl-, 3.380(3); N(H)\u22c5\u22c5\u22c5N, 2.953(2) \u00c5], and (f) piracetam2\u22c5CaCl2\u22c52H2O [N(H)\u22c5\u22c5\u22c5Cl-, 3.42(1) and 3.63(1) \u00c5; H atoms not located, but N(H)\u22c5\u22c5\u22c5Cl hydrogen bonds are comparable to those observed in the Sr analogue]. Color codes are as in Figure ; gray, carbon; light gray, hydrogen. Hwater atoms are not shown for clarity.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 30, "type": "text", "classification": ["else"], "content": "<p>A further point worth noting is that crystalline nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O differs from all other ICCs we have studied until now in that calcium coordination involves also the nicotinamide heterocyclic nitrogen. This is not unexpected, because the heterocyclic nitrogen acts as an acceptor for hydrogen bonding. Thus, the possibility of forming stable ICCs is likely to be extended to other kinds of acceptors and donors such as aromatic heterocylic nitrogens.</p>", "clean_text": "A further point worth noting is that crystalline nicotinamide\u22c5CaCl2\u22c5H2O differs from all other ICCs we have studied until now in that calcium coordination involves also the nicotinamide heterocyclic nitrogen. This is not unexpected, because the heterocyclic nitrogen acts as an acceptor for hydrogen bonding. Thus, the possibility of forming stable ICCs is likely to be extended to other kinds of acceptors and donors such as aromatic heterocylic nitrogens.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 31, "type": "text", "classification": ["else"], "content": "<p>In terms of preparation methods, all ICCs described herein were synthesized by mechanochemical solid-state techniques (grinding and kneading) with quantitative reactions, except for nicotinamide<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O, which can only be obtained as a crystalline material directly from solution. Dry grinding of nicotinamide<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O produces nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O.</p>", "clean_text": "In terms of preparation methods, all ICCs described herein were synthesized by mechanochemical solid-state techniques (grinding and kneading) with quantitative reactions, except for nicotinamide2\u22c5CaCl2\u22c52H2O, which can only be obtained as a crystalline material directly from solution. Dry grinding of nicotinamide2\u22c5CaCl2\u22c52H2O produces nicotinamide\u22c5CaCl2\u22c5H2O.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 32, "type": "text", "classification": "error", "content": "<title>Physical Properties of ICCs with Piracetam and Nicotinamide</title><p>As stated in the introduction, the effect of ICCs formation on physical properties has been tested, because of their possible applications in the pharmaceutical field.</p><p>IDR measurements (see the ) show that ICCs of piracetam and nicotinamide have a lower IDR in physiological solution than the corresponding pure APIs: 136.4 vs 262.8 mg L<sup>\u20131</sup> min<sup>\u20131</sup> and 187.7 vs 379.4 mg L<sup>\u20131</sup> min<sup>\u20131</sup>, respectively. These differences are significant, as ICC formation almost halves the IDR value.</p>", "clean_text": "Physical Properties of ICCs with Piracetam and Nicotinamide\n\nAs stated in the introduction, the effect of ICCs formation on physical properties has been tested, because of their possible applications in the pharmaceutical field.\n\nIDR measurements (see the ) show that ICCs of piracetam and nicotinamide have a lower IDR in physiological solution than the corresponding pure APIs: 136.4 vs 262.8 mg L-1 min-1 and 187.7 vs 379.4 mg L-1 min-1, respectively. These differences are significant, as ICC formation almost halves the IDR value.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 33, "type": "text", "classification": "error", "content": "<p>Beside the difference in IDR, the thermal stability of both APIs is enhanced in ICCs with respect to the pure components. While pure nicotinamide melts at 132 \u00b0C, nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O is stable up to 142 \u00b0C, as shown by variable temperature powder XRPD analysis (see Figure ). At this temperature, nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O converts into another crystalline form, presumably the corresponding anhydrous nicotinamide\u00b7CaCl<sub>2</sub> ICC, which is still stable at 240 \u00b0C.</p>", "clean_text": "Beside the difference in IDR, the thermal stability of both APIs is enhanced in ICCs with respect to the pure components. While pure nicotinamide melts at 132 \u00b0C, nicotinamide\u22c5CaCl2\u22c5H2O is stable up to 142 \u00b0C, as shown by variable temperature powder XRPD analysis (see Figure ). At this temperature, nicotinamide\u22c5CaCl2\u22c5H2O converts into another crystalline form, presumably the corresponding anhydrous nicotinamide\u22c5CaCl2 ICC, which is still stable at 240 \u00b0C.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 34, "type": "figure", "classification": null, "content": "<fig id=\"fig7\" orientation=\"portrait\" position=\"float\">\n<label>7</label>\n<caption>\n<p>XRPD patterns for nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O at room temperature (bottom curve) and at 240 \u00b0C (top curve).</p>\n</caption>\n<graphic id=\"gr7\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2011-01177p_0007.tif\"></graphic>\n</fig>", "clean_text": " 7  XRPD patterns for nicotinamide\u22c5CaCl2\u22c5H2O at room temperature (bottom curve) and at 240 \u00b0C (top curve).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 35, "type": "text", "classification": "error", "content": "<p>Analogously, while pure piracetam melts at 127 \u00b0C, the ICC piracetam<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O transforms at around 140 \u00b0C (see Figure ) into another crystalline compound (possibly the anhydrous form), which is still stable at 180 \u00b0C. So far, we have not managed to determine the structures of these high temperature, stable phases, but it is our interest to explore these issues in a future work.</p>", "clean_text": "Analogously, while pure piracetam melts at 127 \u00b0C, the ICC piracetam2\u22c5CaCl2\u22c52H2O transforms at around 140 \u00b0C (see Figure ) into another crystalline compound (possibly the anhydrous form), which is still stable at 180 \u00b0C. So far, we have not managed to determine the structures of these high temperature, stable phases, but it is our interest to explore these issues in a future work.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 36, "type": "figure", "classification": null, "content": "<fig id=\"fig8\" orientation=\"portrait\" position=\"float\">\n<label>8</label>\n<caption>\n<p>XRPD patterns for piracetam\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O at room temperature (bottom curve) and at 180 \u00b0C (top curve).</p>\n</caption>\n<graphic id=\"gr8\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2011-01177p_0008.tif\"></graphic>\n</fig>", "clean_text": " 8  XRPD patterns for piracetam\u22c5CaCl2\u22c52H2O at room temperature (bottom curve) and at 180 \u00b0C (top curve).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 37, "type": "text", "classification": ["else"], "content": "<title>Conclusions and Outlook</title><p>In this paper, we have reported the preparation and full structural characterization of a series of novel ICCs obtained quantitatively by mechanochemical treament of the organic molecules barbituric acid, diacetamide, malonamide, and piracetam, while the inorganic salt coformer is CaCl<sub>2</sub>. Nicotinamide<sub>2</sub>\u00b7CaCl <sub>2</sub> \u00b72H <sub>2</sub>O was only obtained by direct crystallization from solution. All of these ICCs possess structures whose stability can be accounted for in terms of the \u201csolvation properties\u201d of the primary and secondary amides toward the anions and cations of the inorganic salt. These interactions undoubtedly provide the extra thermodynamic drive toward formation of cocrystals with respect to crystallization as separate entities. Water is often brought into the crystal, and this is also crucial in the formation of intermolecular and interionic hydrogen bonds. Removal of water still leads to the formation of stable compounds, but we have thus far been unable to fully characterize the high-temperature anhydrous phases.</p>", "clean_text": "Conclusions and Outlook\n\nIn this paper, we have reported the preparation and full structural characterization of a series of novel ICCs obtained quantitatively by mechanochemical treament of the organic molecules barbituric acid, diacetamide, malonamide, and piracetam, while the inorganic salt coformer is CaCl2. Nicotinamide2\u22c5CaCl 2 \u22c52H 2O was only obtained by direct crystallization from solution. All of these ICCs possess structures whose stability can be accounted for in terms of the \"solvation properties\" of the primary and secondary amides toward the anions and cations of the inorganic salt. These interactions undoubtedly provide the extra thermodynamic drive toward formation of cocrystals with respect to crystallization as separate entities. Water is often brought into the crystal, and this is also crucial in the formation of intermolecular and interionic hydrogen bonds. Removal of water still leads to the formation of stable compounds, but we have thus far been unable to fully characterize the high-temperature anhydrous phases.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 38, "type": "text", "classification": ["else"], "content": "<p>In the cases of piracetam<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O and nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O, we have also shown that some physical properties of ICC may differ significantly from those of pure organic components. For instance, the thermal stability of piracetam<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O and nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O is greatly enhanced with respect to that of the pure API themselves. On the other hand, IDR values for both compounds are lower for the ICCs than for pure piracetam and nicotinamide, respectively. The high-temperature behavior of ICCs can be very important for industrial processes as well. We are currently working on the crystal structure determination of the nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O and piracetam<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O high-temperature phases.</p>", "clean_text": "In the cases of piracetam2\u22c5CaCl2\u22c52H2O and nicotinamide\u22c5CaCl2\u22c5H2O, we have also shown that some physical properties of ICC may differ significantly from those of pure organic components. For instance, the thermal stability of piracetam2\u22c5CaCl2\u22c52H2O and nicotinamide\u22c5CaCl2\u22c5H2O is greatly enhanced with respect to that of the pure API themselves. On the other hand, IDR values for both compounds are lower for the ICCs than for pure piracetam and nicotinamide, respectively. The high-temperature behavior of ICCs can be very important for industrial processes as well. We are currently working on the crystal structure determination of the nicotinamide\u22c5CaCl2\u22c5H2O and piracetam2\u22c5CaCl2\u22c52H2O high-temperature phases.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 39, "type": "text", "classification": ["else"], "content": "<p>The structure of nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O showed also the possibility of exploiting N\u00b7\u00b7\u00b7Ca interactions as an alternative to C\ue5fbO\u00b7\u00b7\u00b7Ca interactions: The heterocyclic nitrogen can play an analogous role in the metal atom coordination. We aim to further explore solvation properties of molecules characterized by different kinds of dipoles such as aromatic heterocyclic nitrogens.</p>", "clean_text": "The structure of nicotinamide\u22c5CaCl2\u22c5H2O showed also the possibility of exploiting N\u22c5\u22c5\u22c5Ca interactions as an alternative to C\ue5fbO\u22c5\u22c5\u22c5Ca interactions: The heterocyclic nitrogen can play an analogous role in the metal atom coordination. We aim to further explore solvation properties of molecules characterized by different kinds of dipoles such as aromatic heterocyclic nitrogens.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 40, "type": "text", "classification": ["else"], "content": "<p>Clearly, the development of an adequate strategy for structure determination directly from powder data has been quintessential to the develeopment of this solid-state chemistry, since the products are easily obtained by mechanical mixing of the reactants. Furthermore, the possibility of using common laboratory diffraction instruments widens up the perspective of direct structural determination of complex structures of ICCs.</p>", "clean_text": "Clearly, the development of an adequate strategy for structure determination directly from powder data has been quintessential to the develeopment of this solid-state chemistry, since the products are easily obtained by mechanical mixing of the reactants. Furthermore, the possibility of using common laboratory diffraction instruments widens up the perspective of direct structural determination of complex structures of ICCs.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 41, "type": "text", "classification": ["else"], "content": "<p>Crystallografic information files (cif) for all strucures described herein. This material is available free of charge via the Internet at <uri xlink:href=\"http://pubs.acs.org\">http://pubs.acs.org</uri>.</p><title>References</title>", "clean_text": "Crystallografic information files (cif) for all strucures described herein. This material is available free of charge via the Internet at http://pubs.acs.org.\n\nReferences", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}], "cln_elements": [{"idx": 10, "type": "table", "classification": ["Crystal"], "content": "<table-wrap id=\"tbl1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<title>ICCs Obtained as Single Crystals or Powders from Solution and Solid-State Processes</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup align=\"left\" cols=\"3\">\n<oasis:colspec colname=\"col1\"></oasis:colspec>\n<oasis:colspec colname=\"col2\"></oasis:colspec>\n<oasis:colspec colname=\"col3\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\">ICC formula</oasis:entry>\n<oasis:entry align=\"center\">synthesis technique</oasis:entry>\n<oasis:entry align=\"center\">structural solution</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>malonamide\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O</oasis:entry>\n<oasis:entry>solution/kneading</oasis:entry>\n<oasis:entry>single crystal</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>piracetam<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O</oasis:entry>\n<oasis:entry>kneading</oasis:entry>\n<oasis:entry>powder</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O</oasis:entry>\n<oasis:entry>kneading</oasis:entry>\n<oasis:entry>powder</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>nicotinamide<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O</oasis:entry>\n<oasis:entry>solution</oasis:entry>\n<oasis:entry>single crystal</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>diacetamide\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O</oasis:entry>\n<oasis:entry>solution/kneading</oasis:entry>\n<oasis:entry>single crystal</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>barbituric acid\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O</oasis:entry>\n<oasis:entry>solution/kneading</oasis:entry>\n<oasis:entry>single crystal</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>piracetam<sub>2</sub>\u00b7SrCl<sub>2</sub>\u00b72H<sub>2</sub>O</oasis:entry>\n<oasis:entry>solution</oasis:entry>\n<oasis:entry>single crystal</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n</table-wrap>", "clean_text": "Table 1. ICCs Obtained as Single Crystals or Powders from Solution and Solid-State Processes\n\n| ICC formula | synthesis technique | structural solution |\n|-------------|----------------------|----------------------|\n| malonamide\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O | solution/kneading | single crystal |\n| piracetam<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O | kneading | powder |\n| nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O | kneading | powder |\n| nicotinamide<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O | solution | single crystal |\n| diacetamide\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O | solution/kneading | single crystal |\n| barbituric acid\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O | solution/kneading | single crystal |\n| piracetam<sub>2</sub>\u00b7SrCl<sub>2</sub>\u00b72H<sub>2</sub>O | solution | single crystal |", "data": [["No properties found"]], "include_properties": ["chemical_formula"], "intermediate_step": {"table-convert2MD": "[gpt.ft]Table 1. ICCs Obtained as Single Crystals or Powders from Solution and Solid-State Processes\n\n| ICC formula | synthesis technique | structural solution |\n|-------------|----------------------|----------------------|\n| malonamide\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O | solution/kneading | single crystal |\n| piracetam<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O | kneading | powder |\n| nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O | kneading | powder |\n| nicotinamide<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O | solution | single crystal |\n| diacetamide\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O | solution/kneading | single crystal |\n| barbituric acid\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O | solution/kneading | single crystal |\n| piracetam<sub>2</sub>\u00b7SrCl<sub>2</sub>\u00b72H<sub>2</sub>O | solution | single crystal |\n<END>", "table-categorize": "Crystal", "table-crystal-categorize": "['chemical_formula']"}}, {"idx": 17, "type": "table", "classification": ["Crystal"], "content": "<table-wrap id=\"tbl2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<title>Crystallographic Details for Malonamide\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O, Diacetamide\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O, Barbituric Acid\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O, Nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O, Nicotinamide<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O, Piracetam<sub>2</sub>\u00b7SrCl<sub>2</sub>\u00b72H<sub>2</sub>O, and Piracetam<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup align=\"left\" cols=\"8\">\n<oasis:colspec colname=\"col1\"></oasis:colspec>\n<oasis:colspec colname=\"col2\"></oasis:colspec>\n<oasis:colspec colname=\"col3\"></oasis:colspec>\n<oasis:colspec colname=\"col4\"></oasis:colspec>\n<oasis:colspec colname=\"col5\"></oasis:colspec>\n<oasis:colspec colname=\"col6\"></oasis:colspec>\n<oasis:colspec colname=\"col7\"></oasis:colspec>\n<oasis:colspec colname=\"col8\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\"></oasis:entry>\n<oasis:entry align=\"center\">malonamide\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O</oasis:entry>\n<oasis:entry align=\"center\">diacetamide\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O</oasis:entry>\n<oasis:entry align=\"center\">barbituric acid\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O</oasis:entry>\n<oasis:entry align=\"center\">nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O<xref rid=\"t2fn1\"></xref>\n</oasis:entry>\n<oasis:entry align=\"center\">nicotinamide<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O</oasis:entry>\n<oasis:entry align=\"center\">piracetam<sub>2</sub>\u00b7SrCl<sub>2</sub>\u00b72H<sub>2</sub>O</oasis:entry>\n<oasis:entry align=\"center\">piracetam<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O<xref rid=\"t2fn1\"></xref>\n</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>chemical formula</oasis:entry>\n<oasis:entry>C<sub>3</sub>H<sub>10</sub>CaCl<sub>2</sub>N<sub>2</sub>O<sub>4</sub>\n</oasis:entry>\n<oasis:entry>C<sub>4</sub>H<sub>17</sub>CaCl<sub>2</sub>NO<sub>7</sub>\n</oasis:entry>\n<oasis:entry>C<sub>4</sub>H<sub>14</sub>CaCl<sub>2</sub>N<sub>2</sub>O<sub>8</sub>\n</oasis:entry>\n<oasis:entry>C<sub>6</sub>CaCl<sub>2</sub>N<sub>2</sub>O<sub>2</sub>\n</oasis:entry>\n<oasis:entry>C<sub>12</sub>H<sub>16</sub>CaCl<sub>2</sub>N<sub>4</sub>O<sub>4</sub>\n</oasis:entry>\n<oasis:entry>C<sub>12</sub>H<sub>24</sub>SrCl<sub>2</sub>N<sub>4</sub>O<sub>6</sub>\n</oasis:entry>\n<oasis:entry>C<sub>12</sub>CaCl<sub>2</sub>N<sub>4</sub>O<sub>6</sub>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">M</italic>\n<sub>r</sub>\n</oasis:entry>\n<oasis:entry>294.11</oasis:entry>\n<oasis:entry>302.17</oasis:entry>\n<oasis:entry>329.15</oasis:entry>\n<oasis:entry>243.06</oasis:entry>\n<oasis:entry>391.27</oasis:entry>\n<oasis:entry>478.87</oasis:entry>\n<oasis:entry>407.14</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>crystal system</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">P</italic>1\u0305</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">P</italic> 2<sub>1</sub>\n</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">P</italic> 2<sub>1</sub>/<italic toggle=\"yes\">c</italic>\n</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">P</italic>1\u0305</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">C</italic>2/<italic toggle=\"yes\">c</italic>\n</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">P</italic> 2<sub>1</sub>/<italic toggle=\"yes\">n</italic>\n</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">P</italic> 2<sub>1</sub>/<italic toggle=\"yes\">n</italic>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>space group</oasis:entry>\n<oasis:entry>triclinic</oasis:entry>\n<oasis:entry>monoclinic</oasis:entry>\n<oasis:entry>monoclinic</oasis:entry>\n<oasis:entry>triclinic</oasis:entry>\n<oasis:entry>monoclinic</oasis:entry>\n<oasis:entry>monoclinic</oasis:entry>\n<oasis:entry>monoclinic</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">a</italic> (\u00c5)</oasis:entry>\n<oasis:entry>5.9055(4)</oasis:entry>\n<oasis:entry>7.8917(5)</oasis:entry>\n<oasis:entry>8.9583(7)</oasis:entry>\n<oasis:entry>9.6884(2)</oasis:entry>\n<oasis:entry>21.740(1)</oasis:entry>\n<oasis:entry>8.9444(5)</oasis:entry>\n<oasis:entry>8.89548(8)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">b</italic> (\u00c5)</oasis:entry>\n<oasis:entry>8.0258(5)</oasis:entry>\n<oasis:entry>7.2632(5)</oasis:entry>\n<oasis:entry>21.060(2)</oasis:entry>\n<oasis:entry>9.2781(1)</oasis:entry>\n<oasis:entry>6.872(3)</oasis:entry>\n<oasis:entry>9.8519(4)</oasis:entry>\n<oasis:entry>9.6092(1)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">c</italic> (\u00c5)</oasis:entry>\n<oasis:entry>11.5035(6)</oasis:entry>\n<oasis:entry>12.9379(8)</oasis:entry>\n<oasis:entry>8.9583(7)</oasis:entry>\n<oasis:entry>6.1967(1)</oasis:entry>\n<oasis:entry>12.8167(7)</oasis:entry>\n<oasis:entry>11.8823(7)</oasis:entry>\n<oasis:entry>11.9274(1)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b1 (deg)</oasis:entry>\n<oasis:entry>71.208(5)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>103.036(2)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>90</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b2 (deg)</oasis:entry>\n<oasis:entry>80.134(5)</oasis:entry>\n<oasis:entry>102.815(7)</oasis:entry>\n<oasis:entry>130.34(1)</oasis:entry>\n<oasis:entry>98.564(1)</oasis:entry>\n<oasis:entry>117.775(7)</oasis:entry>\n<oasis:entry>106.520(7)</oasis:entry>\n<oasis:entry>108.0589(6)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b3 (deg)</oasis:entry>\n<oasis:entry>85.297(5)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>107.858(2)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>90</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">V</italic> (\u00c5<sup>3</sup>)</oasis:entry>\n<oasis:entry>508.32(5)</oasis:entry>\n<oasis:entry>723.12(8)</oasis:entry>\n<oasis:entry>1288.3(2)</oasis:entry>\n<oasis:entry>502.027(8)</oasis:entry>\n<oasis:entry>1694.1(2)</oasis:entry>\n<oasis:entry>1003.84(9)</oasis:entry>\n<oasis:entry>969.31(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">Z</italic>\n</oasis:entry>\n<oasis:entry>2</oasis:entry>\n<oasis:entry>2</oasis:entry>\n<oasis:entry>4</oasis:entry>\n<oasis:entry>2</oasis:entry>\n<oasis:entry>4</oasis:entry>\n<oasis:entry>2</oasis:entry>\n<oasis:entry>2</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">d</italic>\n<sub>calcd</sub> (mg cm<sup>\u20133</sup>)</oasis:entry>\n<oasis:entry>1.628</oasis:entry>\n<oasis:entry>1.388</oasis:entry>\n<oasis:entry>1.697</oasis:entry>\n<oasis:entry>7.21</oasis:entry>\n<oasis:entry>1.534</oasis:entry>\n<oasis:entry>1.584</oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03bc (mm<sup>\u20131</sup>)</oasis:entry>\n<oasis:entry>1.124</oasis:entry>\n<oasis:entry>0.816</oasis:entry>\n<oasis:entry>0.931</oasis:entry>\n<oasis:entry>7.02</oasis:entry>\n<oasis:entry>0.709</oasis:entry>\n<oasis:entry>2.985</oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b8 range (\u00b0)</oasis:entry>\n<oasis:entry>3.50\u201327.50</oasis:entry>\n<oasis:entry>3.23\u201329.3</oasis:entry>\n<oasis:entry>2.88\u201327.33</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>3.15\u201329.21</oasis:entry>\n<oasis:entry>3.14\u201328.79</oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>reflns collected/unique</oasis:entry>\n<oasis:entry>2625/1715</oasis:entry>\n<oasis:entry>3488/1881</oasis:entry>\n<oasis:entry>5365/2364</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>3759/1561</oasis:entry>\n<oasis:entry>3524/1506</oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">R</italic>\n<sub>int</sub>\n</oasis:entry>\n<oasis:entry>0.011</oasis:entry>\n<oasis:entry>0.019</oasis:entry>\n<oasis:entry>0.022</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>0.026</oasis:entry>\n<oasis:entry>0.028</oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>GoF</oasis:entry>\n<oasis:entry>0.845</oasis:entry>\n<oasis:entry>1.059</oasis:entry>\n<oasis:entry>1.05</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>1.093</oasis:entry>\n<oasis:entry>0.933</oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">R</italic>\n<sub>1</sub> (obsd)</oasis:entry>\n<oasis:entry>0.0251</oasis:entry>\n<oasis:entry>0.0551</oasis:entry>\n<oasis:entry>0.0318</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>0.0384</oasis:entry>\n<oasis:entry>0.0377</oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">wR</italic>\n<sub>2</sub> (all)</oasis:entry>\n<oasis:entry>0.0682</oasis:entry>\n<oasis:entry>0.1497</oasis:entry>\n<oasis:entry>0.0715</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>0.088</oasis:entry>\n<oasis:entry>0.0750</oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">R</italic>\n<sub>wp</sub>\n</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>7.21</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>9.11</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">R</italic>\n<sub>\n<italic toggle=\"yes\">F</italic>2</sub>\n</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>7.02</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>9.54</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03c7<sup>2</sup>\n</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>1.031</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>2.202</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t2fn1\">\n<label>a</label>\n<p>Powder data.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "Table 2. Crystallographic Details for Malonamide\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O, Diacetamide\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O, Barbituric Acid\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O, Nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O, Nicotinamide<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O, Piracetam<sub>2</sub>\u00b7SrCl<sub>2</sub>\u00b72H<sub>2</sub>O, and Piracetam<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O\n\n|                   | malonamide\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O | diacetamide\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O | barbituric acid\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O | nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O<sup>a</sup> | nicotinamide<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O | piracetam<sub>2</sub>\u00b7SrCl<sub>2</sub>\u00b72H<sub>2</sub>O | piracetam<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O<sup>a</sup> |\n|-------------------|----------------------------------------|---------------------------------------|-----------------------------------------|-------------------------------------------------|---------------------------------------------------|-------------------------------------------------|---------------------------------------------------|\n| chemical formula  | C<sub>3</sub>H<sub>10</sub>CaCl<sub>2</sub>N<sub>2</sub>O<sub>4</sub> | C<sub>4</sub>H<sub>17</sub>CaCl<sub>2</sub>NO<sub>7</sub> | C<sub>4</sub>H<sub>14</sub>CaCl<sub>2</sub>N<sub>2</sub>O<sub>8</sub> | C<sub>6</sub>CaCl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> | C<sub>12</sub>H<sub>16</sub>CaCl<sub>2</sub>N<sub>4</sub>O<sub>4</sub> | C<sub>12</sub>H<sub>24</sub>SrCl<sub>2</sub>N<sub>4</sub>O<sub>6</sub> | C<sub>12</sub>CaCl<sub>2</sub>N<sub>4</sub>O<sub>6</sub> |\n| <italic>M</italic><sub>r</sub> | 294.11                                 | 302.17                                | 329.15                                  | 243.06                                          | 391.27                                            | 478.87                                          | 407.14                                            |\n| crystal system    | <italic>P</italic>1\u0305                      | <italic>P</italic> 2<sub>1</sub>       | <italic>P</italic> 2<sub>1</sub>/<italic>c</italic>       | <italic>P</italic>1\u0305                               | <italic>C</italic>2/<italic>c</italic>                 | <italic>P</italic> 2<sub>1</sub>/<italic>n</italic>       | <italic>P</italic> 2<sub>1</sub>/<italic>n</italic>         |\n| space group       | triclinic                              | monoclinic                            | monoclinic                               | triclinic                                       | monoclinic                                         | monoclinic                                       | monoclinic                                         |\n| <italic>a</italic> (\u00c5) | 5.9055(4)                              | 7.8917(5)                            | 8.9583(7)                               | 9.6884(2)                                       | 21.740(1)                                         | 8.9444(5)                                       | 8.89548(8)                                         |\n| <italic>b</italic> (\u00c5) | 8.0258(5)                              | 7.2632(5)                            | 21.060(2)                               | 9.2781(1)                                       | 6.872(3)                                          | 9.8519(4)                                       | 9.6092(1)                                          |\n| <italic>c</italic> (\u00c5) | 11.5035(6)                             | 12.9379(8)                           | 8.9583(7)                               | 6.1967(1)                                       | 12.8167(7)                                        | 11.8823(7)                                      | 11.9274(1)                                         |\n| \u03b1 (deg)           | 71.208(5)                              | 90                                    | 90                                      | 103.036(2)                                      | 90                                                | 90                                              | 90                                                |\n| \u03b2 (deg)           | 80.134(5)                              | 102.815(7)                           | 130.34(1)                               | 98.564(1)                                       | 117.775(7)                                        | 106.520(7)                                      | 108.0589(6)                                        |\n| \u03b3 (deg)           | 85.297(5)                              | 90                                    | 90                                      | 107.858(2)                                      | 90                                                | 90                                              | 90                                                |\n| <italic>V</italic> (\u00c5<sup>3</sup>) | 508.32(5)                              | 723.12(8)                            | 1288.3(2)                               | 502.027(8)                                      | 1694.1(2)                                         | 1003.84(9)                                      | 969.31(2)                                          |\n| <italic>Z</italic>       | 2                                      | 2                                     | 4                                       | 2                                               | 4                                                 | 2                                               | 2                                                 |\n| <italic>d</italic><sub>calcd</sub> (mg cm<sup>\u20133</sup>) | 1.628                                  | 1.388                                 | 1.697                                   | 7.21                                            | 1.534                                             | 1.584                                           |                                                     |\n| \u03bc (mm<sup>\u20131</sup>) | 1.124                                  | 0.816                                 | 0.931                                   | 7.02                                            | 0.709                                             | 2.985                                           |                                                     |\n| \u03b8 range (\u00b0)       | 3.50\u201327.50                              | 3.23\u201329.3                            | 2.88\u201327.33                               |                                                 | 3.15\u201329.21                                        | 3.14\u201328.79                                      |                                                     |\n| reflns collected/unique | 2625/1715                              | 3488/1881                            | 5365/2364                               |                                                 | 3759/1561                                          | 3524/1506                                        |                                                     |\n| <italic>R</italic><sub>int</sub> | 0.011                                  | 0.019                                 | 0.022                                   |                                                 | 0.026                                             | 0.028                                           |                                                     |\n| GoF               | 0.845                                  | 1.059                                 | 1.05                                    |                                                 | 1.093                                             | 0.933                                           |                                                     |\n| <italic>R</italic><sub>1</sub> (obsd) | 0.0251                                 | 0.0551                                | 0.0318                                  |                                                 | 0.0384                                            | 0.0377                                          |                                                     |\n| <italic>wR</italic><sub>2</sub> (all) | 0.0682                                 | 0.1497                                | 0.0715                                  |                                                 | 0.088                                             | 0.0750                                          |                                                     |\n| <italic>R</italic><sub>wp</sub> |                                        |                                       |                                         | 7.21                                            |                                                   |                                                 | 9.11                                                |\n| <italic>R</italic><sub><italic>F</italic>2</sub> |                                        |                                       |                                         | 7.02                                            |                                                   |                                                 | 9.54                                                |\n| \u03c7<sup>2</sup>     |                                        |                                       |                                         | 1.031                                           |                                                   |                                                 | 2.202                                               |", "data": [[{"meta": {"name": "malonamide\u00b7CaCl2\u00b72H2O", "symbol": "", "chemical formula": "C3H10CaCl2N2O4"}, "chemical formula weight": [{"value": "294.11", "unit": "", "condition": ""}], "crystal system": [{"value": "triclinic", "condition": ""}], "space group": [{"value": "P1\u0305", "condition": ""}], "lattice parameters": [{"value": {"a": "5.9055(4)", "b": "8.0258(5)", "c": "11.5035(6)", "alpha": "71.208(5)", "beta": "80.134(5)", "gamma": "85.297(5)"}, "condition": ""}], "cell volume": [{"value": "508.32(5)", "unit": "\u00c5^3", "condition": ""}], "density": [{"value": "1.628", "unit": "mg/cm^3", "condition": ""}]}, {"meta": {"name": "diacetamide\u00b7CaCl2\u00b75H2O", "symbol": "", "chemical formula": "C4H17CaCl2NO7"}, "chemical formula weight": [{"value": "302.17", "unit": "", "condition": ""}], "crystal system": [{"value": "monoclinic", "condition": ""}], "space group": [{"value": "P 21", "condition": ""}], "lattice parameters": [{"value": {"a": "7.8917(5)", "b": "7.2632(5)", "c": "12.9379(8)", "alpha": "90", "beta": "102.815(7)", "gamma": "90"}, "condition": ""}], "cell volume": [{"value": "723.12(8)", "unit": "\u00c5^3", "condition": ""}], "density": [{"value": "1.388", "unit": "mg/cm^3", "condition": ""}]}, {"meta": {"name": "barbituric acid\u00b7CaCl2\u00b75H2O", "symbol": "", "chemical formula": "C4H14CaCl2N2O8"}, "chemical formula weight": [{"value": "329.15", "unit": "", "condition": ""}], "crystal system": [{"value": "monoclinic", "condition": ""}], "space group": [{"value": "P 21/c", "condition": ""}], "lattice parameters": [{"value": {"a": "8.9583(7)", "b": "21.060(2)", "c": "8.9583(7)", "alpha": "90", "beta": "130.34(1)", "gamma": "90"}, "condition": ""}], "cell volume": [{"value": "1288.3(2)", "unit": "\u00c5^3", "condition": ""}], "density": [{"value": "1.697", "unit": "mg/cm^3", "condition": ""}]}, {"meta": {"name": "nicotinamide\u00b7CaCl2\u00b7H2O", "symbol": "", "chemical formula": "C6CaCl2N2O2"}, "crystal system": [{"value": "triclinic", "condition": ""}], "space group": [{"value": "P1\u0305", "condition": ""}], "lattice parameters": [{"value": {"a": "9.6884(2)", "b": "9.2781(1)", "c": "6.1967(1)", "alpha": "103.036(2)", "beta": "98.564(1)", "gamma": "107.858(2)"}, "condition": ""}], "cell volume": [{"value": "502.027(8)", "unit": "\u00c5^3", "condition": ""}], "density": [{"value": "7.21", "unit": "mg/cm^3", "condition": ""}]}, {"meta": {"name": "nicotinamide2\u00b7CaCl2\u00b72H2O", "symbol": "", "chemical formula": "C12H16CaCl2N4O4"}, "chemical formula weight": [{"value": "391.27", "unit": "", "condition": ""}], "crystal system": [{"value": "monoclinic", "condition": ""}], "space group": [{"value": "C2/c", "condition": ""}], "lattice parameters": [{"value": {"a": "21.740(1)", "b": "6.872(3)", "c": "12.8167(7)", "alpha": "90", "beta": "117.775(7)", "gamma": "90"}, "condition": ""}], "cell volume": [{"value": "1694.1(2)", "unit": "\u00c5^3", "condition": ""}], "density": [{"value": "1.534", "unit": "mg/cm^3", "condition": ""}]}, {"meta": {"name": "piracetam2\u00b7SrCl2\u00b72H2O", "symbol": "", "chemical formula": "C12H24SrCl2N4O6"}, "chemical formula weight": [{"value": "478.87", "unit": "", "condition": ""}], "crystal system": [{"value": "monoclinic", "condition": ""}], "space group": [{"value": "P 21/n", "condition": ""}], "lattice parameters": [{"value": {"a": "8.9444(5)", "b": "9.8519(4)", "c": "11.8823(7)", "alpha": "90", "beta": "106.520(7)", "gamma": "90"}, "condition": ""}], "cell volume": [{"value": "1003.84(9)", "unit": "\u00c5^3", "condition": ""}], "density": [{"value": "1.584", "unit": "mg/cm^3", "condition": ""}]}, {"meta": {"name": "piracetam2\u00b7CaCl2\u00b72H2O", "symbol": "", "chemical formula": "C12CaCl2N4O6"}, "chemical formula weight": [{"value": "407.14", "unit": "", "condition": ""}], "crystal system": [{"value": "monoclinic", "condition": ""}], "space group": [{"value": "P 21/n", "condition": ""}], "lattice parameters": [{"value": {"a": "8.89548(8)", "b": "9.6092(1)", "c": "11.9274(1)", "alpha": "90", "beta": "108.0589(6)", "gamma": "90"}, "condition": ""}], "cell volume": [{"value": "969.31(2)", "unit": "\u00c5^3", "condition": ""}], "density": [{"value": "", "unit": "", "condition": ""}]}]], "include_properties": ["chemical_formula", "chemical_formula_weight", "crystal_system", "space_group", "lattice_parameters", "cell_volume", "density"], "intermediate_step": {"table-convert2MD": "[gpt3.5]Table 2. Crystallographic Details for Malonamide\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O, Diacetamide\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O, Barbituric Acid\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O, Nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O, Nicotinamide<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O, Piracetam<sub>2</sub>\u00b7SrCl<sub>2</sub>\u00b72H<sub>2</sub>O, and Piracetam<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O\n\n|                   | malonamide\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O | diacetamide\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O | barbituric acid\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O | nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O<sup>a</sup> | nicotinamide<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O | piracetam<sub>2</sub>\u00b7SrCl<sub>2</sub>\u00b72H<sub>2</sub>O | piracetam<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O<sup>a</sup> |\n|-------------------|----------------------------------------|---------------------------------------|-----------------------------------------|-------------------------------------------------|---------------------------------------------------|-------------------------------------------------|---------------------------------------------------|\n| chemical formula  | C<sub>3</sub>H<sub>10</sub>CaCl<sub>2</sub>N<sub>2</sub>O<sub>4</sub> | C<sub>4</sub>H<sub>17</sub>CaCl<sub>2</sub>NO<sub>7</sub> | C<sub>4</sub>H<sub>14</sub>CaCl<sub>2</sub>N<sub>2</sub>O<sub>8</sub> | C<sub>6</sub>CaCl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> | C<sub>12</sub>H<sub>16</sub>CaCl<sub>2</sub>N<sub>4</sub>O<sub>4</sub> | C<sub>12</sub>H<sub>24</sub>SrCl<sub>2</sub>N<sub>4</sub>O<sub>6</sub> | C<sub>12</sub>CaCl<sub>2</sub>N<sub>4</sub>O<sub>6</sub> |\n| <italic>M</italic><sub>r</sub> | 294.11                                 | 302.17                                | 329.15                                  | 243.06                                          | 391.27                                            | 478.87                                          | 407.14                                            |\n| crystal system    | <italic>P</italic>1\u0305                      | <italic>P</italic> 2<sub>1</sub>       | <italic>P</italic> 2<sub>1</sub>/<italic>c</italic>       | <italic>P</italic>1\u0305                               | <italic>C</italic>2/<italic>c</italic>                 | <italic>P</italic> 2<sub>1</sub>/<italic>n</italic>       | <italic>P</italic> 2<sub>1</sub>/<italic>n</italic>         |\n| space group       | triclinic                              | monoclinic                            | monoclinic                               | triclinic                                       | monoclinic                                         | monoclinic                                       | monoclinic                                         |\n| <italic>a</italic> (\u00c5) | 5.9055(4)                              | 7.8917(5)                            | 8.9583(7)                               | 9.6884(2)                                       | 21.740(1)                                         | 8.9444(5)                                       | 8.89548(8)                                         |\n| <italic>b</italic> (\u00c5) | 8.0258(5)                              | 7.2632(5)                            | 21.060(2)                               | 9.2781(1)                                       | 6.872(3)                                          | 9.8519(4)                                       | 9.6092(1)                                          |\n| <italic>c</italic> (\u00c5) | 11.5035(6)                             | 12.9379(8)                           | 8.9583(7)                               | 6.1967(1)                                       | 12.8167(7)                                        | 11.8823(7)                                      | 11.9274(1)                                         |\n| \u03b1 (deg)           | 71.208(5)                              | 90                                    | 90                                      | 103.036(2)                                      | 90                                                | 90                                              | 90                                                |\n| \u03b2 (deg)           | 80.134(5)                              | 102.815(7)                           | 130.34(1)                               | 98.564(1)                                       | 117.775(7)                                        | 106.520(7)                                      | 108.0589(6)                                        |\n| \u03b3 (deg)           | 85.297(5)                              | 90                                    | 90                                      | 107.858(2)                                      | 90                                                | 90                                              | 90                                                |\n| <italic>V</italic> (\u00c5<sup>3</sup>) | 508.32(5)                              | 723.12(8)                            | 1288.3(2)                               | 502.027(8)                                      | 1694.1(2)                                         | 1003.84(9)                                      | 969.31(2)                                          |\n| <italic>Z</italic>       | 2                                      | 2                                     | 4                                       | 2                                               | 4                                                 | 2                                               | 2                                                 |\n| <italic>d</italic><sub>calcd</sub> (mg cm<sup>\u20133</sup>) | 1.628                                  | 1.388                                 | 1.697                                   | 7.21                                            | 1.534                                             | 1.584                                           |                                                     |\n| \u03bc (mm<sup>\u20131</sup>) | 1.124                                  | 0.816                                 | 0.931                                   | 7.02                                            | 0.709                                             | 2.985                                           |                                                     |\n| \u03b8 range (\u00b0)       | 3.50\u201327.50                              | 3.23\u201329.3                            | 2.88\u201327.33                               |                                                 | 3.15\u201329.21                                        | 3.14\u201328.79                                      |                                                     |\n| reflns collected/unique | 2625/1715                              | 3488/1881                            | 5365/2364                               |                                                 | 3759/1561                                          | 3524/1506                                        |                                                     |\n| <italic>R</italic><sub>int</sub> | 0.011                                  | 0.019                                 | 0.022                                   |                                                 | 0.026                                             | 0.028                                           |                                                     |\n| GoF               | 0.845                                  | 1.059                                 | 1.05                                    |                                                 | 1.093                                             | 0.933                                           |                                                     |\n| <italic>R</italic><sub>1</sub> (obsd) | 0.0251                                 | 0.0551                                | 0.0318                                  |                                                 | 0.0384                                            | 0.0377                                          |                                                     |\n| <italic>wR</italic><sub>2</sub> (all) | 0.0682                                 | 0.1497                                | 0.0715                                  |                                                 | 0.088                                             | 0.0750                                          |                                                     |\n| <italic>R</italic><sub>wp</sub> |                                        |                                       |                                         | 7.21                                            |                                                   |                                                 | 9.11                                                |\n| <italic>R</italic><sub><italic>F</italic>2</sub> |                                        |                                       |                                         | 7.02                                            |                                                   |                                                 | 9.54                                                |\n| \u03c7<sup>2</sup>     |                                        |                                       |                                         | 1.031                                           |                                                   |                                                 | 2.202                                               |\n<END>", "table-categorize": "Crystal", "table-crystal-categorize": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"malonamide\u00b7CaCl2\u00b72H2O\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"C3H10CaCl2N2O4\",\n        },\n        \"chemical formula weight\": [\n            {\n                \"value\": \"294.11\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            }\n        ],\n        \"crystal system\": [\n            {\n                \"value\": \"triclinic\",\n                \"condition\": \"\",\n            }\n        ],\n        \"space group\": [\n            {\n                \"value\": \"P1\u0305\",\n                \"condition\": \"\",\n            }\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"5.9055(4)\",\n                    \"b\": \"8.0258(5)\",\n                    \"c\": \"11.5035(6)\",\n                    \"alpha\": \"71.208(5)\",\n                    \"beta\": \"80.134(5)\",\n                    \"gamma\": \"85.297(5)\"\n                },\n                \"condition\": \"\",\n            }\n        ],\n        \"cell volume\": [\n            {\n                \"value\": \"508.32(5)\",\n                \"unit\": \"\u00c5^3\",\n                \"condition\": \"\",\n            }\n        ],\n        \"density\": [\n            {\n                \"value\": \"1.628\",\n                \"unit\": \"mg/cm^3\",\n                \"condition\": \"\",\n            }\n        ]\n    },\n    {\n        \"meta\": {\n            \"name\": \"diacetamide\u00b7CaCl2\u00b75H2O\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"C4H17CaCl2NO7\",\n        },\n        \"chemical formula weight\": [\n            {\n                \"value\": \"302.17\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            }\n        ],\n        \"crystal system\": [\n            {\n                \"value\": \"monoclinic\",\n                \"condition\": \"\",\n            }\n        ],\n        \"space group\": [\n            {\n                \"value\": \"P 21\",\n                \"condition\": \"\",\n            }\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"7.8917(5)\",\n                    \"b\": \"7.2632(5)\",\n                    \"c\": \"12.9379(8)\",\n                    \"alpha\": \"90\",\n                    \"beta\": \"102.815(7)\",\n                    \"gamma\": \"90\"\n                },\n                \"condition\": \"\",\n            }\n        ],\n        \"cell volume\": [\n            {\n                \"value\": \"723.12(8)\",\n                \"unit\": \"\u00c5^3\",\n                \"condition\": \"\",\n            }\n        ],\n        \"density\": [\n            {\n                \"value\": \"1.388\",\n                \"unit\": \"mg/cm^3\",\n                \"condition\": \"\",\n            }\n        ]\n    },\n    {\n        \"meta\": {\n            \"name\": \"barbituric acid\u00b7CaCl2\u00b75H2O\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"C4H14CaCl2N2O8\",\n        },\n        \"chemical formula weight\": [\n            {\n                \"value\": \"329.15\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            }\n        ],\n        \"crystal system\": [\n            {\n                \"value\": \"monoclinic\",\n                \"condition\": \"\",\n            }\n        ],\n        \"space group\": [\n            {\n                \"value\": \"P 21/c\",\n                \"condition\": \"\",\n            }\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"8.9583(7)\",\n                    \"b\": \"21.060(2)\",\n                    \"c\": \"8.9583(7)\",\n                    \"alpha\": \"90\",\n                    \"beta\": \"130.34(1)\",\n                    \"gamma\": \"90\"\n                },\n                \"condition\": \"\",\n            }\n        ],\n        \"cell volume\": [\n            {\n                \"value\": \"1288.3(2)\",\n                \"unit\": \"\u00c5^3\",\n                \"condition\": \"\",\n            }\n        ],\n        \"density\": [\n            {\n                \"value\": \"1.697\",\n                \"unit\": \"mg/cm^3\",\n                \"condition\": \"\",\n            }\n        ]\n    },\n    {\n        \"meta\": {\n            \"name\": \"nicotinamide\u00b7CaCl2\u00b7H2O\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"C6CaCl2N2O2\",\n        },\n        \"crystal system\": [\n            {\n                \"value\": \"triclinic\",\n                \"condition\": \"\",\n            }\n        ],\n        \"space group\": [\n            {\n                \"value\": \"P1\u0305\",\n                \"condition\": \"\",\n            }\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"9.6884(2)\",\n                    \"b\": \"9.2781(1)\",\n                    \"c\": \"6.1967(1)\",\n                    \"alpha\": \"103.036(2)\",\n                    \"beta\": \"98.564(1)\",\n                    \"gamma\": \"107.858(2)\"\n                },\n                \"condition\": \"\",\n            }\n        ],\n        \"cell volume\": [\n            {\n                \"value\": \"502.027(8)\",\n                \"unit\": \"\u00c5^3\",\n                \"condition\": \"\",\n            }\n        ],\n        \"density\": [\n            {\n                \"value\": \"7.21\",\n                \"unit\": \"mg/cm^3\",\n                \"condition\": \"\",\n            }\n        ]\n    },\n    {\n        \"meta\": {\n            \"name\": \"nicotinamide2\u00b7CaCl2\u00b72H2O\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"C12H16CaCl2N4O4\",\n        },\n        \"chemical formula weight\": [\n            {\n                \"value\": \"391.27\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            }\n        ],\n        \"crystal system\": [\n            {\n                \"value\": \"monoclinic\",\n                \"condition\": \"\",\n            }\n        ],\n        \"space group\": [\n            {\n                \"value\": \"C2/c\",\n                \"condition\": \"\",\n            }\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"21.740(1)\",\n                    \"b\": \"6.872(3)\",\n                    \"c\": \"12.8167(7)\",\n                    \"alpha\": \"90\",\n                    \"beta\": \"117.775(7)\",\n                    \"gamma\": \"90\"\n                },\n                \"condition\": \"\",\n            }\n        ],\n        \"cell volume\": [\n            {\n                \"value\": \"1694.1(2)\",\n                \"unit\": \"\u00c5^3\",\n                \"condition\": \"\",\n            }\n        ],\n        \"density\": [\n            {\n                \"value\": \"1.534\",\n                \"unit\": \"mg/cm^3\",\n                \"condition\": \"\",\n            }\n        ]\n    },\n    {\n        \"meta\": {\n            \"name\": \"piracetam2\u00b7SrCl2\u00b72H2O\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"C12H24SrCl2N4O6\",\n        },\n        \"chemical formula weight\": [\n            {\n                \"value\": \"478.87\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            }\n        ],\n        \"crystal system\": [\n            {\n                \"value\": \"monoclinic\",\n                \"condition\": \"\",\n            }\n        ],\n        \"space group\": [\n            {\n                \"value\": \"P 21/n\",\n                \"condition\": \"\",\n            }\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"8.9444(5)\",\n                    \"b\": \"9.8519(4)\",\n                    \"c\": \"11.8823(7)\",\n                    \"alpha\": \"90\",\n                    \"beta\": \"106.520(7)\",\n                    \"gamma\": \"90\"\n                },\n                \"condition\": \"\",\n            }\n        ],\n        \"cell volume\": [\n            {\n                \"value\": \"1003.84(9)\",\n                \"unit\": \"\u00c5^3\",\n                \"condition\": \"\",\n            }\n        ],\n        \"density\": [\n            {\n                \"value\": \"1.584\",\n                \"unit\": \"mg/cm^3\",\n                \"condition\": \"\",\n            }\n        ]\n    },\n    {\n        \"meta\": {\n            \"name\": \"piracetam2\u00b7CaCl2\u00b72H2O\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"C12CaCl2N4O6\",\n        },\n        \"chemical formula weight\": [\n            {\n                \"value\": \"407.14\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            }\n        ],\n        \"crystal system\": [\n            {\n                \"value\": \"monoclinic\",\n                \"condition\": \"\",\n            }\n        ],\n        \"space group\": [\n            {\n                \"value\": \"P 21/n\",\n                \"condition\": \"\",\n            }\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"8.89548(8)\",\n                    \"b\": \"9.6092(1)\",\n                    \"c\": \"11.9274(1)\",\n                    \"alpha\": \"90\",\n                    \"beta\": \"108.0589(6)\",\n                    \"gamma\": \"90\"\n                },\n                \"condition\": \"\",\n            }\n        ],\n        \"cell volume\": [\n            {\n                \"value\": \"969.31(2)\",\n                \"unit\": \"\u00c5^3\",\n                \"condition\": \"\",\n            }\n        ],\n        \"density\": [\n            {\n                \"value\": \"\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            }\n        ]\n    }\n]\n```"}}, {"idx": 9, "type": "figure", "classification": null, "content": "<fig id=\"fig1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<p>Organic components used in the preparation of ICCs with CaCl<sub>2</sub>.</p>\n</caption>\n<graphic id=\"gr1\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2011-01177p_0001.tif\"></graphic>\n</fig>", "clean_text": " 1  Organic components used in the preparation of ICCs with CaCl2.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 21, "type": "figure", "classification": null, "content": "<fig id=\"fig2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<p>Experimental (red crosses), calculated (green curve), and difference (purple curve) powder patterns for piracetam<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O; the <italic toggle=\"yes\">x</italic>-axis is in degrees of 2\u03b8. Peak positions are marked in black.</p>\n</caption>\n<graphic id=\"gr2\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2011-01177p_0002.tif\"></graphic>\n</fig>", "clean_text": " 2  Experimental (red crosses), calculated (green curve), and difference (purple curve) powder patterns for piracetam2\u22c5CaCl2\u22c52H2O; the x-axis is in degrees of 2\u03b8. Peak positions are marked in black.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 23, "type": "figure", "classification": null, "content": "<fig id=\"fig3\" orientation=\"portrait\" position=\"float\">\n<label>3</label>\n<caption>\n<p>Experimental (red crosses), calculated (green curve), and difference (purple curve) powder patterns for nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O; the <italic toggle=\"yes\">x</italic>-axis is in degrees of 2\u03b8. Peak positions are marked in black.</p>\n</caption>\n<graphic id=\"gr3\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2011-01177p_0003.tif\"></graphic>\n</fig>", "clean_text": " 3  Experimental (red crosses), calculated (green curve), and difference (purple curve) powder patterns for nicotinamide\u22c5CaCl2\u22c5H2O; the x-axis is in degrees of 2\u03b8. Peak positions are marked in black.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 25, "type": "figure", "classification": null, "content": "<fig id=\"fig4\" orientation=\"portrait\" position=\"float\">\n<label>4</label>\n<caption>\n<p>Packing patterns for (a) malonamide\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O, (b) piracetam<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O, (c) nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O, (d) nicotinamide<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O, (e) diacetamide\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O, and (f) barbituric acid\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O. Color codes: orange, calcium cations and coordination polyhedra; green, chloride ions; gray, carbon; blue, nitrogen; and red, oxygen. Hydrogen atoms not shown for clarity. The software TOPOS was used for all graphical representations.<xref ref-type=\"bibr\" rid=\"ref13\"></xref>\n</p>\n</caption>\n<graphic id=\"gr4\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2011-01177p_0004.tif\"></graphic>\n</fig>", "clean_text": " 4  Packing patterns for (a) malonamide\u22c5CaCl2\u22c52H2O, (b) piracetam2\u22c5CaCl2\u22c52H2O, (c) nicotinamide\u22c5CaCl2\u22c5H2O, (d) nicotinamide2\u22c5CaCl2\u22c52H2O, (e) diacetamide\u22c5CaCl2\u22c55H2O, and (f) barbituric acid\u22c5CaCl2\u22c55H2O. Color codes: orange, calcium cations and coordination polyhedra; green, chloride ions; gray, carbon; blue, nitrogen; and red, oxygen. Hydrogen atoms not shown for clarity. The software TOPOS was used for all graphical representations.    ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 27, "type": "figure", "classification": null, "content": "<fig id=\"fig5\" orientation=\"portrait\" position=\"float\">\n<label>5</label>\n<caption>\n<p>Coordination polyhedra around the calcium cation in (a) malonamide\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O, (b) piracetam<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O, (c) nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O, (d) nicotinamide<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O, (e) diacetamide\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O, and (f) barbituric acid\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O. Color codes: orange, calcium cations; green, chloride ions; blue, nitrogen; red, amido oxygen; and light blue, water oxygen.</p>\n</caption>\n<graphic id=\"gr5\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2011-01177p_0005.tif\"></graphic>\n</fig>", "clean_text": " 5  Coordination polyhedra around the calcium cation in (a) malonamide\u22c5CaCl2\u22c52H2O, (b) piracetam2\u22c5CaCl2\u22c52H2O, (c) nicotinamide\u22c5CaCl2\u22c5H2O, (d) nicotinamide2\u22c5CaCl2\u22c52H2O, (e) diacetamide\u22c5CaCl2\u22c55H2O, and (f) barbituric acid\u22c5CaCl2\u22c55H2O. Color codes: orange, calcium cations; green, chloride ions; blue, nitrogen; red, amido oxygen; and light blue, water oxygen.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 29, "type": "figure", "classification": null, "content": "<fig id=\"fig6\" orientation=\"portrait\" position=\"float\">\n<label>6</label>\n<caption>\n<p>Relevant hydrogen-bonding interactions involving the organic moieties in (a) barbituric acid\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O [O<sub>CO</sub>\u00b7\u00b7\u00b7(H)O<sub>water</sub> in the range 2.809(3)\u20132.982(3); N(H)\u00b7\u00b7\u00b7Cl<sup>\u2013</sup>, 3.263(4) and 3.275(3) \u00c5], (b) diacetamide\u00b7CaCl<sub>2</sub>\u00b75H<sub>2</sub>O [O<sub>CO</sub>\u00b7\u00b7\u00b7(H)O<sub>water</sub>, 2.777(8) and 2.993(7); N(H)\u00b7\u00b7\u00b7Cl<sup>\u2013</sup>, 3.227(5) \u00c5], (c) malonamide\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O [N(H)\u00b7\u00b7\u00b7Cl<sup>\u2013</sup> in the range 3.310(2)\u20133.481(2); N(H)\u00b7\u00b7\u00b7O<sub>water</sub>, 3.144(3) \u00c5], (d) nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O [N(H)\u00b7\u00b7\u00b7Cl<sup>\u2013</sup>, 3.29(1) and 3.31(1)], (e) nicotinamide<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O [N(H)\u00b7\u00b7\u00b7Cl<sup>\u2013</sup>, 3.380(3); N(H)\u00b7\u00b7\u00b7N, 2.953(2) \u00c5], and (f) piracetam<sub>2</sub>\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O [N(H)\u00b7\u00b7\u00b7Cl<sup>\u2013</sup>, 3.42(1) and 3.63(1) \u00c5; H atoms not located, but N(H)\u00b7\u00b7\u00b7Cl hydrogen bonds are comparable to those observed in the Sr analogue]. Color codes are as in Figure <xref rid=\"fig5\"></xref>; gray, carbon; light gray, hydrogen. H<sub>water</sub> atoms are not shown for clarity.</p>\n</caption>\n<graphic id=\"gr6\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2011-01177p_0006.tif\"></graphic>\n</fig>", "clean_text": " 6  Relevant hydrogen-bonding interactions involving the organic moieties in (a) barbituric acid\u22c5CaCl2\u22c55H2O [OCO\u22c5\u22c5\u22c5(H)Owater in the range 2.809(3)-2.982(3); N(H)\u22c5\u22c5\u22c5Cl-, 3.263(4) and 3.275(3) \u00c5], (b) diacetamide\u22c5CaCl2\u22c55H2O [OCO\u22c5\u22c5\u22c5(H)Owater, 2.777(8) and 2.993(7); N(H)\u22c5\u22c5\u22c5Cl-, 3.227(5) \u00c5], (c) malonamide\u22c5CaCl2\u22c52H2O [N(H)\u22c5\u22c5\u22c5Cl- in the range 3.310(2)-3.481(2); N(H)\u22c5\u22c5\u22c5Owater, 3.144(3) \u00c5], (d) nicotinamide\u22c5CaCl2\u22c5H2O [N(H)\u22c5\u22c5\u22c5Cl-, 3.29(1) and 3.31(1)], (e) nicotinamide2\u22c5CaCl2\u22c52H2O [N(H)\u22c5\u22c5\u22c5Cl-, 3.380(3); N(H)\u22c5\u22c5\u22c5N, 2.953(2) \u00c5], and (f) piracetam2\u22c5CaCl2\u22c52H2O [N(H)\u22c5\u22c5\u22c5Cl-, 3.42(1) and 3.63(1) \u00c5; H atoms not located, but N(H)\u22c5\u22c5\u22c5Cl hydrogen bonds are comparable to those observed in the Sr analogue]. Color codes are as in Figure ; gray, carbon; light gray, hydrogen. Hwater atoms are not shown for clarity.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 34, "type": "figure", "classification": null, "content": "<fig id=\"fig7\" orientation=\"portrait\" position=\"float\">\n<label>7</label>\n<caption>\n<p>XRPD patterns for nicotinamide\u00b7CaCl<sub>2</sub>\u00b7H<sub>2</sub>O at room temperature (bottom curve) and at 240 \u00b0C (top curve).</p>\n</caption>\n<graphic id=\"gr7\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2011-01177p_0007.tif\"></graphic>\n</fig>", "clean_text": " 7  XRPD patterns for nicotinamide\u22c5CaCl2\u22c5H2O at room temperature (bottom curve) and at 240 \u00b0C (top curve).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 36, "type": "figure", "classification": null, "content": "<fig id=\"fig8\" orientation=\"portrait\" position=\"float\">\n<label>8</label>\n<caption>\n<p>XRPD patterns for piracetam\u00b7CaCl<sub>2</sub>\u00b72H<sub>2</sub>O at room temperature (bottom curve) and at 180 \u00b0C (top curve).</p>\n</caption>\n<graphic id=\"gr8\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2011-01177p_0008.tif\"></graphic>\n</fig>", "clean_text": " 8  XRPD patterns for piracetam\u22c5CaCl2\u22c52H2O at room temperature (bottom curve) and at 180 \u00b0C (top curve).   ", "data": null, "include_properties": null, "intermediate_step": {}}], "metadata": {"doi": "10.1021/cg201177p", "title": "\nIonic Co-crystals of Organic Molecules with Metal Halides: A New Prospect in the Solid Formulation of Active Pharmaceutical Ingredients\n", "journal": "American Chemical Society", "date": "2011.10", "author_list": ["Braga\nDario", "Grepioni\nFabrizia", "Lampronti\nGiulio I.", "Maini\nLucia", "Turrina\nAlessandro"]}}